<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Public Health</journal-id><journal-id journal-id-type="iso-abbrev">Front Public Health</journal-id><journal-id journal-id-type="pmc-domain-id">2277</journal-id><journal-id journal-id-type="pmc-domain">frontpubhealth</journal-id><journal-id journal-id-type="publisher-id">Front. Public Health</journal-id><journal-title-group><journal-title>Frontiers in Public Health</journal-title></journal-title-group><issn pub-type="epub">2296-2565</issn><publisher><publisher-name>Frontiers Media SA</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10291625</article-id><article-id pub-id-type="pmcid-ver">PMC10291625.1</article-id><article-id pub-id-type="pmcaid">10291625</article-id><article-id pub-id-type="pmcaiid">10291625</article-id><article-id pub-id-type="pmid">37377555</article-id><article-id pub-id-type="doi">10.3389/fpubh.2023.1137230</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Public Health</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Estimates of the global, regional, and national burden of atrial fibrillation in older adults from 1990 to 2019: insights from the Global Burden of Disease study 2019</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Jiao</surname><given-names initials="M">Min</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="fn002" ref-type="author-notes">
<sup>&#8224;</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/2139736/overview"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Liu</surname><given-names initials="C">Chenglin</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="fn002" ref-type="author-notes">
<sup>&#8224;</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Liu</surname><given-names initials="Y">Yongwen</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/2315240/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wang</surname><given-names initials="Y">Yan</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Gao</surname><given-names initials="Q">Qianqian</given-names></name><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="c002" ref-type="corresp">
<sup>*</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/1630864/overview"/></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Ma</surname><given-names initials="A">Anning</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="c001" ref-type="corresp">
<sup>*</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://loop.frontiersin.org/people/2055094/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>School of Public Health, Weifang Medical University</institution>, <addr-line>Weifang</addr-line>, <country>China</country></aff><aff id="aff2"><sup>2</sup><institution>Department of Cardiology, Affiliated Hospital of Jining Medical University</institution>, <addr-line>Jining</addr-line>, <country>China</country></aff><aff id="aff3"><sup>3</sup><institution>School of Management, Weifang Medical University</institution>, <addr-line>Weifang</addr-line>, <country>China</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Edwin Van Teijlingen, Bournemouth University, United Kingdom</p></fn><fn fn-type="edited-by"><p>Reviewed by: Shilpa Gaidhane, Datta Meghe Institute of Medical Sciences, India; Guglielmo M. Trovato, University of Catania, Italy; Cosmin Mihai Vesa, University of Oradea, Romania</p></fn><corresp id="c001">*Correspondence: Anning Ma <email>man@wfmc.edu.cn</email></corresp><corresp id="c002">Qianqian Gao <email>wfgaoqq@163.com</email></corresp><fn fn-type="equal" id="fn002"><p>&#8224;These authors have contributed equally to this work</p></fn></author-notes><pub-date pub-type="epub"><day>12</day><month>6</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>11</volume><issue-id pub-id-type="pmc-issue-id">427737</issue-id><elocation-id>1137230</elocation-id><history><date date-type="received"><day>04</day><month>1</month><year>2023</year></date><date date-type="accepted"><day>12</day><month>5</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>12</day><month>06</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>27</day><month>06</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-06-28 17:25:09.517"><day>28</day><month>06</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2023 Jiao, Liu, Liu, Wang, Gao and Ma.</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Jiao, Liu, Liu, Wang, Gao and Ma</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="fpubh-11-1137230.pdf"/><abstract><sec><title>Background</title><p>Atrial fibrill ation (AF) is a predominant public health concern in older adults. Therefore, this study aimed to explore the global, regional, and national burden of AF in older adults aged 60&#8211;89 between 1990 and 2019.</p></sec><sec><title>Methods</title><p>The morbidity, mortality, disability-adjusted life years (DALYs), and age-standardized rates of AF were refined from the Global Burden of Diseases study 2019. The epidemiological characteristics were assessed based on numerical values, age-standardized rates per 100,000 person-years, and estimated annual percentage changes (EAPC).</p></sec><sec><title>Results</title><p>Globally, a total of 33.31 million AF cases, 219.4 thousand deaths, and 65.80 million DALYs were documented in 2019. There were no appreciable changes in EAPC from 1990 to 2019. The disease burden of AF differed significantly across different territories and countries. At the national level, China exhibited the highest number of incident cases [818,493 (562,871&#8211;1,128,695)], deaths [39,970 (33,722&#8211;46,387)], and DALYs [1,383,674 (1,047,540&#8211;1,802,516)]. At the global level, high body mass index (BMI) and high systolic blood pressure (SBP) were two predominant risk factors contributing to the proportion of AF-related deaths.</p></sec><sec><title>Conclusion</title><p>AF in older adults remains a major public health concern worldwide. The burden of AF varies widely at both national and regional levels. From 1990 to 2019, the cases of incidences, deaths, and DALYs have shown a global increase. The ASIR, ASMR, and ASDR have declined in the high-moderate and high SDI regions; however, the burden of AF increased promptly in the lower SDI regions. Special attention should be paid to the main risk factors for high-risk individuals with AF, which can help control systolic blood pressure and body mass index within normal limits. Over all, it is necessary to illustrate the features of the global AF burden and develop more effective and targeted prevention and treatment strategies.</p></sec></abstract><kwd-group><kwd>atrial fibrillation</kwd><kwd>aging</kwd><kwd>Global Burden of Disease</kwd><kwd>risk factors</kwd><kwd>older adults</kwd></kwd-group><counts><fig-count count="6"/><table-count count="1"/><equation-count count="0"/><ref-count count="62"/><page-count count="15"/><word-count count="8434"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Aging and Public Health</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>Atrial fibrillation (AF) is a common cardiac arrhythmia (<xref rid="B1" ref-type="bibr">1</xref>), affecting more than 33 million people. Globally, it is a primary cause of coronary heart disease and mortality (<xref rid="B2" ref-type="bibr">2</xref>). Relevant research indicates that the incidence and prevalence of AF have been going up in Europe and North America from the 1970's to the early twenty-first century (<xref rid="B3" ref-type="bibr">3</xref>). The prevalence of AF is expected to rise in the next 30&#8211;50 years (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>). Hence, AF has become a worldwide public health problem and strained the healthcare system. Understanding the pattern of AF incidence and the temporal trends can facilitate the development of more well-directed preventive measures.</p><p>The Global Burden of Disease (GBD) study estimates the AF burden in 204 countries and territories worldwide, providing an excellent opportunity to comprehend the picture of AF (<xref rid="B6" ref-type="bibr">6</xref>). Recent studies have assessed the prevalence, disability-adjusted life years (DALYs), and AF-related mortality in all age groups using the data derived from the GBD (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B8" ref-type="bibr">8</xref>). However, of all cardiovascular diseases, AF commonly causes heart failure (<xref rid="B9" ref-type="bibr">9</xref>), imposing a substantial disease burden, especially on older adults. The overall health of older adults declines with age, and multimorbidity is prevalent, especially in cardiovascular disease. Therefore, it is necessary to pay particular attention to older adults. A cohort study found a significant increase in the prevalence of AF in older adults over 60 years of age (<xref rid="B10" ref-type="bibr">10</xref>). In addition, the proportion of the older population over 90 years old is only 2%. Therefore, we selected 60&#8211;89-year-olds as the research subjects. Based on the GBD Study 2019 data, the purpose of this study was to explore the burden of AF and its risk factors among older adults aged 60&#8211;89 years at global, regional, and national levels from 1990 to 2019. Our outcomes can act as a crucial supplement and expansion to previous research while also contributing to the formulation of AF prevention measures targeting various countries.</p></sec><sec sec-type="methods" id="s2"><title>Methods</title><sec><title>Data sources</title><p>We collected corresponding data from the Global Health Data Exchange (GHDx) query tool (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://ghdx.healthdata.org/gbd-results-tool" ext-link-type="uri">http://ghdx.healthdata.org/gbd-results-tool</ext-link>) (<xref rid="B11" ref-type="bibr">11</xref>), an online tool of the Global Burden of Diseases (GBD), Etiologies, Injuries, and Risk Factors Study. The quality of statistics has been recognized internationally, and the approaches employed in the GBD have been illustrated elsewhere. The GBD 2019 database consisted of epidemiological data (i.e., deaths, prevalence, incidence, and DALYs) for 204 countries and territories worldwide. Then, these countries and territories were divided into five regions in accordance with the sociodemographic index (SDI) (<xref rid="B2" ref-type="bibr">2</xref>). The regions ranged from high to low as follows: high SDI, high-middle SDI, middle SDI, low-middle SDI, and low SDI.</p><p>Furthermore, the world was geographically divided into 21 regions, such as Australasia and Eastern Europe. The Human Development Index (HDI) data were available for extraction from Human Development Reports (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://hdr.undp.org/en/data" ext-link-type="uri">http://hdr.undp.org/en/data</ext-link>). It was a composite measure index of three elementary aspects of human development: life expectancy, education, and per capita income. In our research, HDI was assembled and utilized to match GBD data. The secondary analysis data in the present article did not require ethical agreement or approval from the ethics committee or the institutional review board.</p></sec><sec><title>Statistical analysis</title><p>The burden of AF was expressed in terms of number, age-standardized incidence rates (ASIRs), age-standardized mortality rates (ASMRs), age-standardized DALY rates (ASDRs), and estimated annual percentage change (EAPC) with a confidence interval of 95%. The ASRs were counted using a standardized global aging structure, which is necessary when comparing populations in different locations or sample groups over a period of time (<xref rid="B12" ref-type="bibr">12</xref>).</p><p>In the present study, we calculated the EAPC in the age-standardized rates of AF to further assess the burden of the disease. EAPC was a generalization and extensively used weighing measure for ASR's tendency within a specified interval. It was calculated using the referring regression line: Y = &#945; + &#946;X + &#949;, where Y referred to ln (age-standardized rate), X presented the calendar year, &#946; influenced the active or passive trends in ASR and &#949; meant error value. The EAPC can be given by the following formula: 100 &#215; [exp (&#946;) &#8211; 1], and its 95% confidence interval (CI) could be obtained from the linear regression model (<xref rid="B12" ref-type="bibr">12</xref>). There are three situations: (1) if the 95% CI and EAPC assessment were both &lt;0, the ASRs were regarded as a descending trend, (2) if the 95% CI and EAPC were both &gt;0, the ASRs were regarded as an increasing trend. (3) If not, the ASRs were regarded as a steady trend. The statistical analysis in the present study was accomplished using the R program (Version 4.1.2). If the <italic toggle="yes">p</italic>-value was &lt;0.05, it was deemed to be statistically significant.</p></sec></sec><sec sec-type="results" id="s3"><title>Results</title><sec><title>Global burden of AF</title><p>At the global level, a total of 3,331,144 (2,342,510&#8211;4,489,654) cases of AF were reported in 2019. The morbidity in both sexes increased by 1.1% from 1,583,024 (1,094,531&#8211;2,166,439) in 1990 to 3,331,144 (2,342,510&#8211;4,489,654) in 2019. Moreover, the ASIR fluctuated slightly by 0.05% from 58.54 (44.92&#8211;74.24) to 57.09 (44.07&#8211;71.9) during the past 30 years. Similarly, the mortality rate increased by 1.36% from 92,801 (82,995&#8211;111,456) in 1990 to 219,437 (190,526&#8211;249,642) in 2019. The ASMR demonstrates a mild increase of 0.04%, from 4.29 (3.73&#8211;5.09) in 1990 to 4.38 (3.7&#8211;5.05) in 2019 per 100,000 population. AF caused 6,579,978 (5,241,696&#8211;8,321,653) DALYs in 2019 worldwide, which was a 1.16% increase from 3,044,717 (2,363,647&#8211;3,900,467) in 1990. With regard to age-standardized rates, in 1990, the ASDR of AF was 110 (87.66&#8211;139.16) per 100,000 population, which slightly decreased to 107.13 (86.18&#8211;133.73) in 2019 (<xref rid="T1" ref-type="table">Table 1</xref>, <xref rid="F1" ref-type="fig">Figure 1A</xref>).</p><table-wrap position="float" id="T1" orientation="portrait"><label>Table 1</label><caption><p>Incident cases, death, and DALYs of cardiomyopathy and myocarditis and ASRs per 10,000 population from 1990 and 2019 by Global Burden of Disease.</p></caption><table frame="box" rules="all"><thead><tr style="background-color:#8f9496"><th valign="top" align="left" rowspan="1" colspan="1">
<bold>Characteristics</bold>
</th><th valign="top" align="left" colspan="2" rowspan="1">
<bold>1990</bold>
</th><th valign="top" align="left" colspan="2" rowspan="1">
<bold>2019</bold>
</th><th valign="top" align="left" rowspan="1" colspan="1">
<bold>1990&#8211;2019</bold>
</th><th valign="top" align="left" rowspan="1" colspan="1">
<bold>1990&#8211;2019</bold>
</th></tr></thead><tbody><tr style="background-color:#8f9496"><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">
<bold>Incidence cases No. (95% UI)</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>ASIR per 100,000 No. (95% UI)</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>Incidence cases No. (95% UI)</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>ASIR per 100,000 No. (95% UI)</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>Percentage change No. (95% CI)</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>EAPC No. (95% CI)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<bold>Overall</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">1,583,023.57 (1,094,531.35&#8211;2,166,438.85)</td><td valign="top" align="left" rowspan="1" colspan="1">58.54 (44.92&#8211;74.24)</td><td valign="top" align="left" rowspan="1" colspan="1">3,331,144.11 (2,342,509.66&#8211;4,489,654.42)</td><td valign="top" align="left" rowspan="1" colspan="1">57.09 (44.07&#8211;71.9)</td><td valign="top" align="left" rowspan="1" colspan="1">1.1% (1.06&#8211;1.16)</td><td valign="top" align="left" rowspan="1" colspan="1">0.05 (&#8722;0.02&#8211;0.13)</td></tr><tr style="background-color:#dee1e1"><td valign="top" align="left" colspan="7" rowspan="1">
<bold>Sociodemographic index</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Low SDI</td><td valign="top" align="left" rowspan="1" colspan="1">59,083.69 (40,267.86&#8211;81,934.91)</td><td valign="top" align="left" rowspan="1" colspan="1">40.67 (30.92&#8211;52.06)</td><td valign="top" align="left" rowspan="1" colspan="1">135,864.94 (92,489.13&#8211;186,062.1)</td><td valign="top" align="left" rowspan="1" colspan="1">41.97 (31.77&#8211;53.69)</td><td valign="top" align="left" rowspan="1" colspan="1">1.19% (1.14&#8211;1.26)</td><td valign="top" align="left" rowspan="1" colspan="1">0.12 (0.11&#8211;0.12)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Low-middle SDI</td><td valign="top" align="left" rowspan="1" colspan="1">202,876.21 (138,996.1&#8211;280,233.52)</td><td valign="top" align="left" rowspan="1" colspan="1">53.96 (41.04&#8211;68.62)</td><td valign="top" align="left" rowspan="1" colspan="1">505,077.85 (346,414.8&#8211;690,949.01)</td><td valign="top" align="left" rowspan="1" colspan="1">54.72 (41.51&#8211;69.76)</td><td valign="top" align="left" rowspan="1" colspan="1">1.48% (1.4&#8211;1.57)</td><td valign="top" align="left" rowspan="1" colspan="1">0.08 (0.06&#8211;0.09)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Middle SDI</td><td valign="top" align="left" rowspan="1" colspan="1">342,872.23 (233,718.56&#8211;470,907.06)</td><td valign="top" align="left" rowspan="1" colspan="1">52.39 (39.69&#8211;66.74)</td><td valign="top" align="left" rowspan="1" colspan="1">922,124.53 (632,539.34&#8211;1,262,914.42)</td><td valign="top" align="left" rowspan="1" colspan="1">54.27 (41.16&#8211;69.05)</td><td valign="top" align="left" rowspan="1" colspan="1">1.57% (1.52&#8211;1.63)</td><td valign="top" align="left" rowspan="1" colspan="1">0.14 (0.08&#8211;0.2)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">High-middle SDI</td><td valign="top" align="left" rowspan="1" colspan="1">435,935.66 (300,652.64&#8211;602,950.05)</td><td valign="top" align="left" rowspan="1" colspan="1">60.34 (46.52&#8211;77.1)</td><td valign="top" align="left" rowspan="1" colspan="1">827,741.17 (571,861.8&#8211;1,134,881.72)</td><td valign="top" align="left" rowspan="1" colspan="1">57.97 (44.57&#8211;74.2)</td><td valign="top" align="left" rowspan="1" colspan="1">0.9% (0.84&#8211;0.96)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.12 (&#8722;0.15 to &#8722;0.09)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">High SDI</td><td valign="top" align="left" rowspan="1" colspan="1">541,597 (376,964.16&#8211;733,826.69)</td><td valign="top" align="left" rowspan="1" colspan="1">71.45 (55.34&#8211;90.2)</td><td valign="top" align="left" rowspan="1" colspan="1">939,060.48 (696,820.22&#8211;1,228,719.31)</td><td valign="top" align="left" rowspan="1" colspan="1">69.22 (55.37&#8211;85.18)</td><td valign="top" align="left" rowspan="1" colspan="1">0.73% (0.63&#8211;0.87)</td><td valign="top" align="left" rowspan="1" colspan="1">0.26 (0.09&#8211;0.44)</td></tr><tr style="background-color:#dee1e1"><td valign="top" align="left" colspan="7" rowspan="1">
<bold>Regions</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Andean-Latin America</td><td valign="top" align="left" rowspan="1" colspan="1">1,894.12 (1,297.77&#8211;2,554.18)</td><td valign="top" align="left" rowspan="1" colspan="1">13.63 (10.08&#8211;17.53)</td><td valign="top" align="left" rowspan="1" colspan="1">6,097.32 (4,265.51&#8211;8,160.3)</td><td valign="top" align="left" rowspan="1" colspan="1">14.84 (11.11&#8211;19.17)</td><td valign="top" align="left" rowspan="1" colspan="1">2.22% (2.07&#8211;2.38)</td><td valign="top" align="left" rowspan="1" colspan="1">0.43 (0.35&#8211;0.52)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Australasia</td><td valign="top" align="left" rowspan="1" colspan="1">17,400.97 (12,027.61&#8211;23,837.67)</td><td valign="top" align="left" rowspan="1" colspan="1">98.68 (75.18&#8211;125.06)</td><td valign="top" align="left" rowspan="1" colspan="1">32,335.39 (22,689.52&#8211;43,431.81)</td><td valign="top" align="left" rowspan="1" colspan="1">90.39 (69.71&#8211;114.51)</td><td valign="top" align="left" rowspan="1" colspan="1">0.86% (0.75&#8211;0.97)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.24 (&#8722;0.3 to &#8722;0.19)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Caribbean</td><td valign="top" align="left" rowspan="1" colspan="1">5,691.5 (3,900.06&#8211;7,753.2)</td><td valign="top" align="left" rowspan="1" colspan="1">29.33 (22.05&#8211;38.08)</td><td valign="top" align="left" rowspan="1" colspan="1">11,441.62 (7,849.53&#8211;15,488.95)</td><td valign="top" align="left" rowspan="1" colspan="1">29.72 (22.18&#8211;38.44)</td><td valign="top" align="left" rowspan="1" colspan="1">1.01% (0.96&#8211;1.07)</td><td valign="top" align="left" rowspan="1" colspan="1">0.07 (0.06&#8211;0.08)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Central Asia</td><td valign="top" align="left" rowspan="1" colspan="1">18,123.03 (12,503.21&#8211;24,707.24)</td><td valign="top" align="left" rowspan="1" colspan="1">63.51 (48.9&#8211;80.87)</td><td valign="top" align="left" rowspan="1" colspan="1">27,908.61 (18,911.11&#8211;38,566.56)</td><td valign="top" align="left" rowspan="1" colspan="1">64.77 (49.64&#8211;82.66)</td><td valign="top" align="left" rowspan="1" colspan="1">0.54% (0.47&#8211;0.6)</td><td valign="top" align="left" rowspan="1" colspan="1">0.1 (0.09&#8211;0.12)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Central Europe</td><td valign="top" align="left" rowspan="1" colspan="1">69,623.44 (47,658.46&#8211;96,047.25)</td><td valign="top" align="left" rowspan="1" colspan="1">72.77 (55.81&#8211;92.66)</td><td valign="top" align="left" rowspan="1" colspan="1">98,521.6 (67,133.05&#8211;136,390.75)</td><td valign="top" align="left" rowspan="1" colspan="1">70.59 (54.18&#8211;89.82)</td><td valign="top" align="left" rowspan="1" colspan="1">0.42% (0.36&#8211;0.46)</td><td valign="top" align="left" rowspan="1" colspan="1">0.02 (&#8722;0.06&#8211;0.11)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Central Latin America</td><td valign="top" align="left" rowspan="1" colspan="1">17,879.46 (12,333.8&#8211;24,307.64)</td><td valign="top" align="left" rowspan="1" colspan="1">31.81 (23.94&#8211;41.05)</td><td valign="top" align="left" rowspan="1" colspan="1">53,721.27 (37,296.58&#8211;73,064.04)</td><td valign="top" align="left" rowspan="1" colspan="1">31.77 (23.84&#8211;41.21)</td><td valign="top" align="left" rowspan="1" colspan="1">2% (1.94&#8211;2.07)</td><td valign="top" align="left" rowspan="1" colspan="1">0.01 (0&#8211;0.02)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Central Sub-Saharan Africa</td><td valign="top" align="left" rowspan="1" colspan="1">4,453.46 (2,990&#8211;6,276.85)</td><td valign="top" align="left" rowspan="1" colspan="1">33.03 (25.06&#8211;42.21)</td><td valign="top" align="left" rowspan="1" colspan="1">9,596.86 (6,537.13&#8211;13,243.4)</td><td valign="top" align="left" rowspan="1" colspan="1">32.22 (24.45&#8211;41.46)</td><td valign="top" align="left" rowspan="1" colspan="1">1.15% (1.01&#8211;1.31)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.1 (&#8722;0.12 to &#8722;0.09)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">East Asia</td><td valign="top" align="left" rowspan="1" colspan="1">313,996.06 (212,426.67&#8211;436,983.35)</td><td valign="top" align="left" rowspan="1" colspan="1">55.26 (41.95&#8211;70.12)</td><td valign="top" align="left" rowspan="1" colspan="1">845,659.53 (583,221.77&#8211;1,164,608.61)</td><td valign="top" align="left" rowspan="1" colspan="1">57.4 (43.67&#8211;72.99)</td><td valign="top" align="left" rowspan="1" colspan="1">1.69% (1.61&#8211;1.8)</td><td valign="top" align="left" rowspan="1" colspan="1">0.16 (0.04&#8211;0.28)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Eastern Europe</td><td valign="top" align="left" rowspan="1" colspan="1">122,722.76 (84,488.3&#8211;167,427.12)</td><td valign="top" align="left" rowspan="1" colspan="1">68.4 (52.4&#8211;87.04)</td><td valign="top" align="left" rowspan="1" colspan="1">167,038.62 (114,134.66&#8211;231,211.1)</td><td valign="top" align="left" rowspan="1" colspan="1">74.4 (57.18&#8211;95.28)</td><td valign="top" align="left" rowspan="1" colspan="1">0.36% (0.32&#8211;0.4)</td><td valign="top" align="left" rowspan="1" colspan="1">0.35 (0.32&#8211;0.38)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Eastern Sub-Saharan Africa</td><td valign="top" align="left" rowspan="1" colspan="1">8,610.45 (5,833.87&#8211;11,972.16)</td><td valign="top" align="left" rowspan="1" colspan="1">19.48 (14.83&#8211;25.05)</td><td valign="top" align="left" rowspan="1" colspan="1">18,593.54 (12,619.36&#8211;25,545)</td><td valign="top" align="left" rowspan="1" colspan="1">19.89 (15.18&#8211;25.61)</td><td valign="top" align="left" rowspan="1" colspan="1">1.16% (1.11&#8211;1.22)</td><td valign="top" align="left" rowspan="1" colspan="1">0.16 (0.1&#8211;0.23)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">High-income Asia Pacific</td><td valign="top" align="left" rowspan="1" colspan="1">31,243.1 (20,944.28&#8211;43,603.15)</td><td valign="top" align="left" rowspan="1" colspan="1">26.92 (20.67&#8211;34.42)</td><td valign="top" align="left" rowspan="1" colspan="1">49,432.85 (33,174.99&#8211;68,914.26)</td><td valign="top" align="left" rowspan="1" colspan="1">21.12 (16.28&#8211;27.19)</td><td valign="top" align="left" rowspan="1" colspan="1">0.58% (0.5&#8211;0.7)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;1.58 (&#8722;1.91 to &#8722;1.24)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">High-income North America</td><td valign="top" align="left" rowspan="1" colspan="1">265,521.57 (184,073.28&#8211;358,286.57)</td><td valign="top" align="left" rowspan="1" colspan="1">95.3 (73.03&#8211;121)</td><td valign="top" align="left" rowspan="1" colspan="1">548,955.86 (418,372.27&#8211;698,785.69)</td><td valign="top" align="left" rowspan="1" colspan="1">108.53 (87.59&#8211;131.44)</td><td valign="top" align="left" rowspan="1" colspan="1">1.07% (0.86&#8211;1.34)</td><td valign="top" align="left" rowspan="1" colspan="1">1.33 (0.95&#8211;1.72)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">North Africa and the Middle East</td><td valign="top" align="left" rowspan="1" colspan="1">45,957.21 (31,425.75&#8211;63,186.57)</td><td valign="top" align="left" rowspan="1" colspan="1">41.81 (31.63&#8211;53.41)</td><td valign="top" align="left" rowspan="1" colspan="1">116,006.36 (80,041.9&#8211;158,616.64)</td><td valign="top" align="left" rowspan="1" colspan="1">41.93 (31.66&#8211;53.56)</td><td valign="top" align="left" rowspan="1" colspan="1">1.52% (1.46&#8211;1.61)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.08 (&#8722;0.11 to &#8722;0.05)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Oceania</td><td valign="top" align="left" rowspan="1" colspan="1">1,027.48 (699.01&#8211;1,447.68)</td><td valign="top" align="left" rowspan="1" colspan="1">57.91 (43.98&#8211;73.48)</td><td valign="top" align="left" rowspan="1" colspan="1">2,374.01 (1,625.76&#8211;3,294.83)</td><td valign="top" align="left" rowspan="1" colspan="1">59.26 (44.94&#8211;75.2)</td><td valign="top" align="left" rowspan="1" colspan="1">1.31% (1.19&#8211;1.43)</td><td valign="top" align="left" rowspan="1" colspan="1">0.07 (0.05&#8211;0.09)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">South Asia</td><td valign="top" align="left" rowspan="1" colspan="1">207,889.94 (142,458.26&#8211;289,158.44)</td><td valign="top" align="left" rowspan="1" colspan="1">60.06 (45.66&#8211;76.21)</td><td valign="top" align="left" rowspan="1" colspan="1">586,125.53 (400,228.16&#8211;804,858.9)</td><td valign="top" align="left" rowspan="1" colspan="1">61.37 (46.53&#8211;78)</td><td valign="top" align="left" rowspan="1" colspan="1">1.82% (1.74&#8211;1.94)</td><td valign="top" align="left" rowspan="1" colspan="1">0.06 (0.06&#8211;0.07)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Southeast Asia</td><td valign="top" align="left" rowspan="1" colspan="1">97,679.58 (66,820.01&#8211;134,561.02)</td><td valign="top" align="left" rowspan="1" colspan="1">61.29 (46.46&#8211;78.2)</td><td valign="top" align="left" rowspan="1" colspan="1">247,606.5 (169,923.94&#8211;339,117.02)</td><td valign="top" align="left" rowspan="1" colspan="1">62.77 (47.54&#8211;79.6)</td><td valign="top" align="left" rowspan="1" colspan="1">1.53% (1.49&#8211;1.58)</td><td valign="top" align="left" rowspan="1" colspan="1">0.09 (0.08&#8211;0.1)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Southern Latin America</td><td valign="top" align="left" rowspan="1" colspan="1">13,914.25 (9,465.08&#8211;18,990.5)</td><td valign="top" align="left" rowspan="1" colspan="1">40.73 (30.74&#8211;52.21)</td><td valign="top" align="left" rowspan="1" colspan="1">25,772.38 (17,760.5&#8211;35,322.51)</td><td valign="top" align="left" rowspan="1" colspan="1">41.8 (31.8&#8211;53.39)</td><td valign="top" align="left" rowspan="1" colspan="1">0.85% (0.76&#8211;0.95)</td><td valign="top" align="left" rowspan="1" colspan="1">0.07 (0&#8211;0.14)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Southern Sub-Saharan Africa</td><td valign="top" align="left" rowspan="1" colspan="1">6,675.23 (4,564.91&#8211;9,166.84)</td><td valign="top" align="left" rowspan="1" colspan="1">37.43 (28.33&#8211;48.01)</td><td valign="top" align="left" rowspan="1" colspan="1">13,535.76 (9,269.77&#8211;18,486.87)</td><td valign="top" align="left" rowspan="1" colspan="1">37.09 (28.17&#8211;47.62)</td><td valign="top" align="left" rowspan="1" colspan="1">1.03% (0.98&#8211;1.08)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.02 (&#8722;0.03 to &#8722;0.01)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Tropical Latin America</td><td valign="top" align="left" rowspan="1" colspan="1">26,492.79 (18,160.56&#8211;36,288.69)</td><td valign="top" align="left" rowspan="1" colspan="1">43.44 (32.89&#8211;55.6)</td><td valign="top" align="left" rowspan="1" colspan="1">77,585.15 (53,528.43&#8211;105,946.86)</td><td valign="top" align="left" rowspan="1" colspan="1">44.8 (33.81&#8211;57.84)</td><td valign="top" align="left" rowspan="1" colspan="1">1.93% (1.84&#8211;2.04)</td><td valign="top" align="left" rowspan="1" colspan="1">0.55 (0.39&#8211;0.7)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Western Europe</td><td valign="top" align="left" rowspan="1" colspan="1">286,609.98 (200,891.8&#8211;389,866.68)</td><td valign="top" align="left" rowspan="1" colspan="1">72.79 (55.34&#8211;92.55)</td><td valign="top" align="left" rowspan="1" colspan="1">352,998.6 (247,983.17&#8211;481,656.6)</td><td valign="top" align="left" rowspan="1" colspan="1">63.01 (48.37&#8211;79.79)</td><td valign="top" align="left" rowspan="1" colspan="1">0.23% (0.2&#8211;0.26)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.36 (&#8722;0.39 to &#8722;0.32)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Western Sub-Saharan Africa</td><td valign="top" align="left" rowspan="1" colspan="1">19,617.2 (13,303.69&#8211;27,132.38)</td><td valign="top" align="left" rowspan="1" colspan="1">35.51 (26.88&#8211;45.46)</td><td valign="top" align="left" rowspan="1" colspan="1">39,836.76 (27,328.41&#8211;54,873.98)</td><td valign="top" align="left" rowspan="1" colspan="1">36.01 (27.33&#8211;46.19)</td><td valign="top" align="left" rowspan="1" colspan="1">1.03% (1&#8211;1.07)</td><td valign="top" align="left" rowspan="1" colspan="1">0.05 (0.01&#8211;0.08)</td></tr><tr style="background-color:#8f9496"><td valign="top" align="left" rowspan="1" colspan="1">
<bold>Characteristics</bold>
</td><td valign="top" align="left" colspan="2" rowspan="1">
<bold>1990</bold>
</td><td valign="top" align="left" colspan="2" rowspan="1">
<bold>2019</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>1990&#8211;2019</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>1990&#8211;2019</bold>
</td></tr><tr style="background-color:#8f9496"><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">
<bold>Deaths cases No. (95% UI)</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>ASMR per 100,000 No. (95% UI)</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>Deaths cases No. (95% UI)</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>ASMR per 100,000 No. (95% UI)</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>Percentage change No. (95% CI)</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>EAPC No. (95% CI)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<bold>Overall</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">92,801.05 (82,995.05&#8211;111,456.15)</td><td valign="top" align="left" rowspan="1" colspan="1">4.29 (3.73&#8211;5.09)</td><td valign="top" align="left" rowspan="1" colspan="1">219,437.14 (190,525.86&#8211;249,642.14)</td><td valign="top" align="left" rowspan="1" colspan="1">4.38 (3.7&#8211;5.05)</td><td valign="top" align="left" rowspan="1" colspan="1">1.36% (1.14&#8211;1.55)</td><td valign="top" align="left" rowspan="1" colspan="1">0.04 (0.02&#8211;0.06)</td></tr><tr style="background-color:#dee1e1"><td valign="top" align="left" colspan="7" rowspan="1">
<bold>Sociodemographic index</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Low SDI</td><td valign="top" align="left" rowspan="1" colspan="1">3,728.16 (2,483.7&#8211;4,731.5)</td><td valign="top" align="left" rowspan="1" colspan="1">3.73 (2.42&#8211;4.76)</td><td valign="top" align="left" rowspan="1" colspan="1">10,484.14 (7,648.72&#8211;12,654.91)</td><td valign="top" align="left" rowspan="1" colspan="1">4.3 (3.08&#8211;5.25)</td><td valign="top" align="left" rowspan="1" colspan="1">1.81% (1.34&#8211;2.51)</td><td valign="top" align="left" rowspan="1" colspan="1">0.5 (0.47&#8211;0.53)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Low-middle SDI</td><td valign="top" align="left" rowspan="1" colspan="1">8,678.73 (6,914.63&#8211;10,558.98)</td><td valign="top" align="left" rowspan="1" colspan="1">3.46 (2.66&#8211;4.14)</td><td valign="top" align="left" rowspan="1" colspan="1">29,699.98 (25,034.79&#8211;34,583.16)</td><td valign="top" align="left" rowspan="1" colspan="1">4.21 (3.5&#8211;4.87)</td><td valign="top" align="left" rowspan="1" colspan="1">2.42% (1.76&#8211;3.14)</td><td valign="top" align="left" rowspan="1" colspan="1">0.61 (0.55&#8211;0.67)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Middle SDI</td><td valign="top" align="left" rowspan="1" colspan="1">16,620.38 (14,704.44&#8211;18,971.98)</td><td valign="top" align="left" rowspan="1" colspan="1">3.82 (3.32&#8211;4.28)</td><td valign="top" align="left" rowspan="1" colspan="1">52,178.17 (45,208.24&#8211;61,158.62)</td><td valign="top" align="left" rowspan="1" colspan="1">4.11 (3.5&#8211;4.75)</td><td valign="top" align="left" rowspan="1" colspan="1">2.14% (1.71&#8211;2.6)</td><td valign="top" align="left" rowspan="1" colspan="1">0.21 (0.19&#8211;0.24)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">High-middle SDI</td><td valign="top" align="left" rowspan="1" colspan="1">27,689.09 (24,854.06&#8211;35,444.35)</td><td valign="top" align="left" rowspan="1" colspan="1">4.64 (4.04&#8211;5.92)</td><td valign="top" align="left" rowspan="1" colspan="1">58,332.62 (50,409.75&#8211;69,838.57)</td><td valign="top" align="left" rowspan="1" colspan="1">4.47 (3.78&#8211;5.39)</td><td valign="top" align="left" rowspan="1" colspan="1">1.11% (0.89&#8211;1.28)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.25 (&#8722;0.32 to &#8722;0.18)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">High SDI</td><td valign="top" align="left" rowspan="1" colspan="1">36,029.71 (31,280.88&#8211;45,846.61)</td><td valign="top" align="left" rowspan="1" colspan="1">4.62 (3.93&#8211;5.82)</td><td valign="top" align="left" rowspan="1" colspan="1">68,619.71 (56,411.87&#8211;81,382)</td><td valign="top" align="left" rowspan="1" colspan="1">4.61 (3.67&#8211;5.52)</td><td valign="top" align="left" rowspan="1" colspan="1">0.9% (0.65&#8211;1.04)</td><td valign="top" align="left" rowspan="1" colspan="1">0.03 (0.01&#8211;0.06)</td></tr><tr style="background-color:#dee1e1"><td valign="top" align="left" colspan="7" rowspan="1">
<bold>Regions</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Andean-Latin America</td><td valign="top" align="left" rowspan="1" colspan="1">504.52 (424.82&#8211;588.91)</td><td valign="top" align="left" rowspan="1" colspan="1">4.41 (3.67&#8211;5.06)</td><td valign="top" align="left" rowspan="1" colspan="1">1,525.05 (1,231.71&#8211;1,852.46)</td><td valign="top" align="left" rowspan="1" colspan="1">4.32 (3.48&#8211;5.24)</td><td valign="top" align="left" rowspan="1" colspan="1">2.02% (1.46&#8211;2.77)</td><td valign="top" align="left" rowspan="1" colspan="1">0.1 (0.03&#8211;0.18)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Australasia</td><td valign="top" align="left" rowspan="1" colspan="1">1,158.23 (958.03&#8211;1,334.33)</td><td valign="top" align="left" rowspan="1" colspan="1">7.38 (5.96&#8211;8.41)</td><td valign="top" align="left" rowspan="1" colspan="1">2,511.5 (2,016.89&#8211;3,042.33)</td><td valign="top" align="left" rowspan="1" colspan="1">6.86 (5.45&#8211;8.33)</td><td valign="top" align="left" rowspan="1" colspan="1">1.17% (0.96&#8211;1.42)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.44 (&#8722;0.52 to &#8722;0.36)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Caribbean</td><td valign="top" align="left" rowspan="1" colspan="1">697.31 (592.49&#8211;813.9)</td><td valign="top" align="left" rowspan="1" colspan="1">4.46 (3.72&#8211;5.28)</td><td valign="top" align="left" rowspan="1" colspan="1">1,549.42 (1,297.45&#8211;1,884.17)</td><td valign="top" align="left" rowspan="1" colspan="1">4.73 (3.91&#8211;5.79)</td><td valign="top" align="left" rowspan="1" colspan="1">1.22% (0.92&#8211;1.56)</td><td valign="top" align="left" rowspan="1" colspan="1">0.26 (0.16&#8211;0.36)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Central Asia</td><td valign="top" align="left" rowspan="1" colspan="1">933.47 (773.86&#8211;1,271.8)</td><td valign="top" align="left" rowspan="1" colspan="1">3.62 (2.82&#8211;4.8)</td><td valign="top" align="left" rowspan="1" colspan="1">1,951.57 (1,721.37&#8211;2,586.44)</td><td valign="top" align="left" rowspan="1" colspan="1">5.75 (4.95&#8211;7.74)</td><td valign="top" align="left" rowspan="1" colspan="1">1.09% (0.62&#8211;1.45)</td><td valign="top" align="left" rowspan="1" colspan="1">1.49 (1.33&#8211;1.64)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Central Europe</td><td valign="top" align="left" rowspan="1" colspan="1">4,332.08 (3,890.56&#8211;5,357.81)</td><td valign="top" align="left" rowspan="1" colspan="1">4.51 (3.93&#8211;5.43)</td><td valign="top" align="left" rowspan="1" colspan="1">8,073.21 (6,837.02&#8211;9,536.65)</td><td valign="top" align="left" rowspan="1" colspan="1">4.83 (3.99&#8211;5.7)</td><td valign="top" align="left" rowspan="1" colspan="1">0.86% (0.61&#8211;1.09)</td><td valign="top" align="left" rowspan="1" colspan="1">0.15 (0.1&#8211;0.2)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Central Latin America</td><td valign="top" align="left" rowspan="1" colspan="1">1,960.79 (1,699.83&#8211;2,517.32)</td><td valign="top" align="left" rowspan="1" colspan="1">4.46 (3.76&#8211;5.68)</td><td valign="top" align="left" rowspan="1" colspan="1">6,478.07 (5,267.49&#8211;8,265.53)</td><td valign="top" align="left" rowspan="1" colspan="1">4.56 (3.72&#8211;5.83)</td><td valign="top" align="left" rowspan="1" colspan="1">2.3% (1.87&#8211;2.71)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.09 (&#8722;0.17 to &#8722;0.01)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Central Sub-Saharan Africa</td><td valign="top" align="left" rowspan="1" colspan="1">467.17 (268.6&#8211;797.97)</td><td valign="top" align="left" rowspan="1" colspan="1">5 (2.85&#8211;8.21)</td><td valign="top" align="left" rowspan="1" colspan="1">1,334.27 (857.82&#8211;1,933.42)</td><td valign="top" align="left" rowspan="1" colspan="1">5.63 (3.55&#8211;8.24)</td><td valign="top" align="left" rowspan="1" colspan="1">1.86% (1.15&#8211;2.84)</td><td valign="top" align="left" rowspan="1" colspan="1">0.37 (0.29&#8211;0.45)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">East Asia</td><td valign="top" align="left" rowspan="1" colspan="1">14,205.46 (1,1974.33&#8211;16,636.49)</td><td valign="top" align="left" rowspan="1" colspan="1">4 (3.31&#8211;4.63)</td><td valign="top" align="left" rowspan="1" colspan="1">41,526.2 (35,287.76&#8211;47,920.9)</td><td valign="top" align="left" rowspan="1" colspan="1">3.82 (3.19&#8211;4.42)</td><td valign="top" align="left" rowspan="1" colspan="1">1.92% (1.36&#8211;2.59)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.26 (&#8722;0.31 to &#8722;0.21)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Eastern Europe</td><td valign="top" align="left" rowspan="1" colspan="1">7,005.17 (6,098.93&#8211;9,688.8)</td><td valign="top" align="left" rowspan="1" colspan="1">4.03 (3.44&#8211;5.6)</td><td valign="top" align="left" rowspan="1" colspan="1">11,419.28 (9,643.68&#8211;14,750.74)</td><td valign="top" align="left" rowspan="1" colspan="1">4.62 (3.88&#8211;6.02)</td><td valign="top" align="left" rowspan="1" colspan="1">0.63% (0.43&#8211;0.83)</td><td valign="top" align="left" rowspan="1" colspan="1">0.22 (0.07&#8211;0.36)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Eastern Sub-Saharan Africa</td><td valign="top" align="left" rowspan="1" colspan="1">1,440.88 (840.03&#8211;1,891.54)</td><td valign="top" align="left" rowspan="1" colspan="1">4.23 (2.37&#8211;5.58)</td><td valign="top" align="left" rowspan="1" colspan="1">3,586.81 (2,304.99&#8211;4,437.21)</td><td valign="top" align="left" rowspan="1" colspan="1">4.69 (2.98&#8211;5.87)</td><td valign="top" align="left" rowspan="1" colspan="1">1.49% (0.99&#8211;2.18)</td><td valign="top" align="left" rowspan="1" colspan="1">0.34 (0.25&#8211;0.43)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">High-income Asia Pacific</td><td valign="top" align="left" rowspan="1" colspan="1">3,746.97 (3,218.5&#8211;4,775.05)</td><td valign="top" align="left" rowspan="1" colspan="1">3 (2.54&#8211;4.03)</td><td valign="top" align="left" rowspan="1" colspan="1">9,103.35 (7,090.93&#8211;11,637.45)</td><td valign="top" align="left" rowspan="1" colspan="1">2.39 (1.87&#8211;3.19)</td><td valign="top" align="left" rowspan="1" colspan="1">1.43% (1.13&#8211;1.72)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.85 (&#8722;0.94 to &#8722;0.75)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">High-income North America</td><td valign="top" align="left" rowspan="1" colspan="1">11,153.7 (9,461.43&#8211;13,912.54)</td><td valign="top" align="left" rowspan="1" colspan="1">4.04 (3.36&#8211;4.99)</td><td valign="top" align="left" rowspan="1" colspan="1">22,725.4 (18,505.88&#8211;27,506.97)</td><td valign="top" align="left" rowspan="1" colspan="1">4.96 (4.01&#8211;6.05)</td><td valign="top" align="left" rowspan="1" colspan="1">1.04% (0.84&#8211;1.12)</td><td valign="top" align="left" rowspan="1" colspan="1">0.72 (0.64&#8211;0.8)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">North Africa and the Middle East</td><td valign="top" align="left" rowspan="1" colspan="1">2,650.72 (2,061.78&#8211;3,059.75)</td><td valign="top" align="left" rowspan="1" colspan="1">3.48 (2.67&#8211;4.11)</td><td valign="top" align="left" rowspan="1" colspan="1">7,696.85 (6,582.67&#8211;9,421.38)</td><td valign="top" align="left" rowspan="1" colspan="1">3.66 (3.07&#8211;4.33)</td><td valign="top" align="left" rowspan="1" colspan="1">1.9% (1.45&#8211;2.87)</td><td valign="top" align="left" rowspan="1" colspan="1">0.19 (0.1&#8211;0.28)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Oceania</td><td valign="top" align="left" rowspan="1" colspan="1">44.44 (32.32&#8211;62.72)</td><td valign="top" align="left" rowspan="1" colspan="1">4.1 (2.76&#8211;6.01)</td><td valign="top" align="left" rowspan="1" colspan="1">121.79 (92.59&#8211;161.5)</td><td valign="top" align="left" rowspan="1" colspan="1">4.25 (3.24&#8211;5.5)</td><td valign="top" align="left" rowspan="1" colspan="1">1.74% (1.25&#8211;2.31)</td><td valign="top" align="left" rowspan="1" colspan="1">0.17 (0.12&#8211;0.22)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">South Asia</td><td valign="top" align="left" rowspan="1" colspan="1">7,479.16 (5,630.22&#8211;9,687.24)</td><td valign="top" align="left" rowspan="1" colspan="1">3.33 (2.41&#8211;4.27)</td><td valign="top" align="left" rowspan="1" colspan="1">29,215.99 (22,995.29&#8211;36,408.38)</td><td valign="top" align="left" rowspan="1" colspan="1">4.1 (3.18&#8211;5.15)</td><td valign="top" align="left" rowspan="1" colspan="1">2.91% (1.92&#8211;4.04)</td><td valign="top" align="left" rowspan="1" colspan="1">0.59 (0.47&#8211;0.71)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Southeast Asia</td><td valign="top" align="left" rowspan="1" colspan="1">3,464.3 (3,046.27&#8211;3,994.08)</td><td valign="top" align="left" rowspan="1" colspan="1">3.19 (2.72&#8211;3.64)</td><td valign="top" align="left" rowspan="1" colspan="1">11,360.88 (9,546.76&#8211;13,785.34)</td><td valign="top" align="left" rowspan="1" colspan="1">3.99 (3.27&#8211;4.75)</td><td valign="top" align="left" rowspan="1" colspan="1">2.28% (1.7&#8211;2.91)</td><td valign="top" align="left" rowspan="1" colspan="1">0.76 (0.7&#8211;0.81)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Southern Latin America</td><td valign="top" align="left" rowspan="1" colspan="1">1,383.83 (1,183.52&#8211;1,701.62)</td><td valign="top" align="left" rowspan="1" colspan="1">4.92 (4.13&#8211;5.93)</td><td valign="top" align="left" rowspan="1" colspan="1">3,074.48 (2,606.14&#8211;4,013.77)</td><td valign="top" align="left" rowspan="1" colspan="1">5.32 (4.44&#8211;6.94)</td><td valign="top" align="left" rowspan="1" colspan="1">1.22% (0.99&#8211;1.46)</td><td valign="top" align="left" rowspan="1" colspan="1">0.29 (0.2&#8211;0.38)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Southern Sub-Saharan Africa</td><td valign="top" align="left" rowspan="1" colspan="1">409.26 (344.19&#8211;464.65)</td><td valign="top" align="left" rowspan="1" colspan="1">3.1 (2.59&#8211;3.5)</td><td valign="top" align="left" rowspan="1" colspan="1">1,045.72 (916.49&#8211;1,151.35)</td><td valign="top" align="left" rowspan="1" colspan="1">3.94 (3.38&#8211;4.37)</td><td valign="top" align="left" rowspan="1" colspan="1">1.56% (1.23&#8211;1.91)</td><td valign="top" align="left" rowspan="1" colspan="1">0.79 (0.59&#8211;0.99)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Tropical Latin America</td><td valign="top" align="left" rowspan="1" colspan="1">2,187.75 (1,873.43&#8211;2,735.8)</td><td valign="top" align="left" rowspan="1" colspan="1">4.78 (3.99&#8211;5.95)</td><td valign="top" align="left" rowspan="1" colspan="1">7,598.03 (6,107.51&#8211;8,898.99)</td><td valign="top" align="left" rowspan="1" colspan="1">5.03 (4.01&#8211;5.94)</td><td valign="top" align="left" rowspan="1" colspan="1">2.47% (1.93&#8211;2.73)</td><td valign="top" align="left" rowspan="1" colspan="1">0.5 (0.32&#8211;0.69)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Western Europe</td><td valign="top" align="left" rowspan="1" colspan="1">25,871.16 (22,624.18&#8211;34,903.21)</td><td valign="top" align="left" rowspan="1" colspan="1">5.77 (4.91&#8211;7.83)</td><td valign="top" align="left" rowspan="1" colspan="1">43,760.97 (35,707.5&#8211;52,790.04)</td><td valign="top" align="left" rowspan="1" colspan="1">5.76 (4.59&#8211;6.99)</td><td valign="top" align="left" rowspan="1" colspan="1">0.69% (0.38&#8211;0.86)</td><td valign="top" align="left" rowspan="1" colspan="1">0.06 (0.02&#8211;0.09)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Western Sub-Saharan Africa</td><td valign="top" align="left" rowspan="1" colspan="1">1,704.67 (1,332.45&#8211;2,229.05)</td><td valign="top" align="left" rowspan="1" colspan="1">4.5 (3.55&#8211;5.93)</td><td valign="top" align="left" rowspan="1" colspan="1">3,778.27 (3,177.8&#8211;4,408.07)</td><td valign="top" align="left" rowspan="1" colspan="1">4.75 (3.89&#8211;5.59)</td><td valign="top" align="left" rowspan="1" colspan="1">1.22% (0.57&#8211;1.76)</td><td valign="top" align="left" rowspan="1" colspan="1">0.08 (0.04&#8211;0.12)</td></tr><tr style="background-color:#8f9496"><td valign="top" align="left" rowspan="1" colspan="1">
<bold>Characteristics</bold>
</td><td valign="top" align="left" colspan="2" rowspan="1">
<bold>1990</bold>
</td><td valign="top" align="left" colspan="2" rowspan="1">
<bold>2019</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>1990&#8211;2019</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>1990&#8211;2019</bold>
</td></tr><tr style="background-color:#8f9496"><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">
<bold>DALYs cases No. (95% UI)</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>ASDR per 100,000 No. (95% UI)</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>DALYs cases No. (95% UI)</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>ASDR per 100,000 No. (95% UI)</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>Percentage change No. (95% CI)</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<bold>EAPC No. (95% CI)</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">
<bold>Overall</bold>
</td><td valign="top" align="left" rowspan="1" colspan="1">3,044,717.13 (2,363,647.01&#8211;3,900,467.06)</td><td valign="top" align="left" rowspan="1" colspan="1">110 (87.66&#8211;139.16)</td><td valign="top" align="left" rowspan="1" colspan="1">6,579,977.8 (5,241,696.12&#8211;8,321,653.38)</td><td valign="top" align="left" rowspan="1" colspan="1">107.13 (86.18&#8211;133.73)</td><td valign="top" align="left" rowspan="1" colspan="1">1.16% (1.06&#8211;1.25)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.03 (&#8722;0.06&#8211;0)</td></tr><tr style="background-color:#dee1e1"><td valign="top" align="left" colspan="7" rowspan="1">
<bold>Sociodemographic index</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Low SDI</td><td valign="top" align="left" rowspan="1" colspan="1">114,659.53 (85,965.49&#8211;146,544.67)</td><td valign="top" align="left" rowspan="1" colspan="1">84.28 (63.03&#8211;105.84)</td><td valign="top" align="left" rowspan="1" colspan="1">287,302.79 (224,193.31&#8211;354,685.81)</td><td valign="top" align="left" rowspan="1" colspan="1">91.91 (71.89&#8211;111.57)</td><td valign="top" align="left" rowspan="1" colspan="1">1.51% (1.27&#8211;1.81)</td><td valign="top" align="left" rowspan="1" colspan="1">0.3 (0.27&#8211;0.33)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Low-middle SDI</td><td valign="top" align="left" rowspan="1" colspan="1">326,477.32 (249,420.63&#8211;425,285.99)</td><td valign="top" align="left" rowspan="1" colspan="1">91.5 (71.71&#8211;114.77)</td><td valign="top" align="left" rowspan="1" colspan="1">927,307.72 (727,621.88&#8211;1,164,150)</td><td valign="top" align="left" rowspan="1" colspan="1">101.01 (81.22&#8211;123.92)</td><td valign="top" align="left" rowspan="1" colspan="1">1.84% (1.58&#8211;2.13)</td><td valign="top" align="left" rowspan="1" colspan="1">0.34 (0.32&#8211;0.37)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Middle SDI</td><td valign="top" align="left" rowspan="1" colspan="1">577,551.29 (444,346.58&#8211;745,572.44)</td><td valign="top" align="left" rowspan="1" colspan="1">93.38 (74.4&#8211;116.56)</td><td valign="top" align="left" rowspan="1" colspan="1">1,648,790.75 (1,285,587.8&#8211;2,095,429.98)</td><td valign="top" align="left" rowspan="1" colspan="1">97.9 (78.07&#8211;122.72)</td><td valign="top" align="left" rowspan="1" colspan="1">1.85% (1.67&#8211;2.05)</td><td valign="top" align="left" rowspan="1" colspan="1">0.17 (0.14&#8211;0.2)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">High-middle SDI</td><td valign="top" align="left" rowspan="1" colspan="1">903,441.18 (702,229.35&#8211;1,176,141.28)</td><td valign="top" align="left" rowspan="1" colspan="1">116.99 (92.57&#8211;149.81)</td><td valign="top" align="left" rowspan="1" colspan="1">1,752,067.46 (1,361,490.97&#8211;2,252,102.91)</td><td valign="top" align="left" rowspan="1" colspan="1">110.21 (86.73&#8211;140.14)</td><td valign="top" align="left" rowspan="1" colspan="1">0.94% (0.84&#8211;1.02)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.25 (&#8722;0.28 to &#8722;0.23)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">High SDI</td><td valign="top" align="left" rowspan="1" colspan="1">1,121,109.75 (882,347.51&#8211;1,445,544.14)</td><td valign="top" align="left" rowspan="1" colspan="1">128.62 (101.73&#8211;165.21)</td><td valign="top" align="left" rowspan="1" colspan="1">1,961,481.71 (1,561,092.24&#8211;2,473,050.53)</td><td valign="top" align="left" rowspan="1" colspan="1">122.64 (97.3&#8211;153.57)</td><td valign="top" align="left" rowspan="1" colspan="1">0.75% (0.64&#8211;0.83)</td><td valign="top" align="left" rowspan="1" colspan="1">0.03 (&#8722;0.05&#8211;0.11)</td></tr><tr style="background-color:#dee1e1"><td valign="top" align="left" colspan="7" rowspan="1">
<bold>Regions</bold>
</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Andean-Latin America</td><td valign="top" align="left" rowspan="1" colspan="1">8,588.77 (7,326.22&#8211;10,022.07)</td><td valign="top" align="left" rowspan="1" colspan="1">64.49 (55.4&#8211;74.42)</td><td valign="top" align="left" rowspan="1" colspan="1">25,568.67 (21,197.9&#8211;30,491.13)</td><td valign="top" align="left" rowspan="1" colspan="1">63.61 (52.67&#8211;75.22)</td><td valign="top" align="left" rowspan="1" colspan="1">1.98% (1.5&#8211;2.57)</td><td valign="top" align="left" rowspan="1" colspan="1">0.11 (0.04&#8211;0.18)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Australasia</td><td valign="top" align="left" rowspan="1" colspan="1">35,222.44 (27,725.1&#8211;45,237.53)</td><td valign="top" align="left" rowspan="1" colspan="1">183.72 (145.83&#8211;231.54)</td><td valign="top" align="left" rowspan="1" colspan="1">70,166.25 (55,042.18&#8211;90,300.77)</td><td valign="top" align="left" rowspan="1" colspan="1">168.28 (132.54&#8211;214.32)</td><td valign="top" align="left" rowspan="1" colspan="1">0.99% (0.89&#8211;1.11)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.36 (&#8722;0.39 to &#8722;0.34)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Caribbean</td><td valign="top" align="left" rowspan="1" colspan="1">14,971.71 (12,424.5&#8211;18,055.44)</td><td valign="top" align="left" rowspan="1" colspan="1">79.4 (66.52&#8211;94.7)</td><td valign="top" align="left" rowspan="1" colspan="1">31,795.63 (26,276.01&#8211;38,251.98)</td><td valign="top" align="left" rowspan="1" colspan="1">83.27 (69.65&#8211;99.83)</td><td valign="top" align="left" rowspan="1" colspan="1">1.12% (0.93&#8211;1.34)</td><td valign="top" align="left" rowspan="1" colspan="1">0.19 (0.13&#8211;0.25)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Central Asia</td><td valign="top" align="left" rowspan="1" colspan="1">35,540.25 (26,530.96&#8211;47,120.72)</td><td valign="top" align="left" rowspan="1" colspan="1">109.82 (82.86&#8211;143.91)</td><td valign="top" align="left" rowspan="1" colspan="1">61,772.11 (47,916.22&#8211;79,286.07)</td><td valign="top" align="left" rowspan="1" colspan="1">138.35 (109.64&#8211;176.31)</td><td valign="top" align="left" rowspan="1" colspan="1">0.74% (0.57&#8211;0.89)</td><td valign="top" align="left" rowspan="1" colspan="1">0.82 (0.76&#8211;0.88)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Central Europe</td><td valign="top" align="left" rowspan="1" colspan="1">155,815.55 (120,452.79&#8211;203,689.02)</td><td valign="top" align="left" rowspan="1" colspan="1">134.74 (105.22&#8211;173.65)</td><td valign="top" align="left" rowspan="1" colspan="1">251,596.5 (195,996.37&#8211;324,725.31)</td><td valign="top" align="left" rowspan="1" colspan="1">136.04 (106.47&#8211;173.32)</td><td valign="top" align="left" rowspan="1" colspan="1">0.61% (0.51&#8211;0.72)</td><td valign="top" align="left" rowspan="1" colspan="1">0.07 (0.01&#8211;0.12)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Central Latin America</td><td valign="top" align="left" rowspan="1" colspan="1">43,319.71 (36,219.34&#8211;53,516.31)</td><td valign="top" align="left" rowspan="1" colspan="1">80.65 (68.44&#8211;98.18)</td><td valign="top" align="left" rowspan="1" colspan="1">138,688.09 (113,679.15&#8211;171,245.23)</td><td valign="top" align="left" rowspan="1" colspan="1">82.84 (68.32&#8211;101.95)</td><td valign="top" align="left" rowspan="1" colspan="1">2.2% (1.93&#8211;2.47)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.01 (&#8722;0.05&#8211;0.04)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Central Sub-Saharan Africa</td><td valign="top" align="left" rowspan="1" colspan="1">122,66.03 (8,247.28&#8211;18,438.06)</td><td valign="top" align="left" rowspan="1" colspan="1">99.09 (65.94&#8211;148.49)</td><td valign="top" align="left" rowspan="1" colspan="1">30,142.71 (21,400.77&#8211;39,321.26)</td><td valign="top" align="left" rowspan="1" colspan="1">104.25 (72.95&#8211;138.1)</td><td valign="top" align="left" rowspan="1" colspan="1">1.46% (0.98&#8211;1.99)</td><td valign="top" align="left" rowspan="1" colspan="1">0.14 (0.07&#8211;0.2)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">East Asia</td><td valign="top" align="left" rowspan="1" colspan="1">519,048.51 (394,223.27&#8211;675,814.17)</td><td valign="top" align="left" rowspan="1" colspan="1">98.28 (76.84&#8211;124.34)</td><td valign="top" align="left" rowspan="1" colspan="1">1,432,517.88 (1,088,053.16&#8211;1,867,068.05)</td><td valign="top" align="left" rowspan="1" colspan="1">96.78 (75.08&#8211;122.56)</td><td valign="top" align="left" rowspan="1" colspan="1">1.76% (1.5&#8211;2.01)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.05 (&#8722;0.13&#8211;0.03)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Eastern Europe</td><td valign="top" align="left" rowspan="1" colspan="1">258,196.1 (196,297.15&#8211;341,308.43)</td><td valign="top" align="left" rowspan="1" colspan="1">120.85 (92.65&#8211;157.62)</td><td valign="top" align="left" rowspan="1" colspan="1">384,777.08 (292,577.71&#8211;503,883.63)</td><td valign="top" align="left" rowspan="1" colspan="1">136.59 (104.82&#8211;177.07)</td><td valign="top" align="left" rowspan="1" colspan="1">0.49% (0.41&#8211;0.57)</td><td valign="top" align="left" rowspan="1" colspan="1">0.36 (0.28&#8211;0.43)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Eastern Sub-Saharan Africa</td><td valign="top" align="left" rowspan="1" colspan="1">31,126.86 (21,024.73&#8211;39,298.52)</td><td valign="top" align="left" rowspan="1" colspan="1">73.06 (48.45&#8211;92.35)</td><td valign="top" align="left" rowspan="1" colspan="1">71,336.96 (50,303.75&#8211;87,335.35)</td><td valign="top" align="left" rowspan="1" colspan="1">77.09 (53.33&#8211;94.33)</td><td valign="top" align="left" rowspan="1" colspan="1">1.29% (0.93&#8211;1.76)</td><td valign="top" align="left" rowspan="1" colspan="1">0.18 (0.1&#8211;0.27)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">High-income Asia Pacific</td><td valign="top" align="left" rowspan="1" colspan="1">94,477.13 (77,636.52&#8211;118,368.25)</td><td valign="top" align="left" rowspan="1" colspan="1">66.35 (54.42&#8211;82.7)</td><td valign="top" align="left" rowspan="1" colspan="1">195,233.79 (157,805.14&#8211;243,046.5)</td><td valign="top" align="left" rowspan="1" colspan="1">53.53 (43.1&#8211;66.58)</td><td valign="top" align="left" rowspan="1" colspan="1">1.07% (0.92&#8211;1.23)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;1.06 (&#8722;1.22 to &#8722;0.91)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">High-income North America</td><td valign="top" align="left" rowspan="1" colspan="1">424,379.23 (327,241.59&#8211;558,162.82)</td><td valign="top" align="left" rowspan="1" colspan="1">140.63 (108.35&#8211;183.61)</td><td valign="top" align="left" rowspan="1" colspan="1">832,025.39 (649,706.07&#8211;1,063,351.64)</td><td valign="top" align="left" rowspan="1" colspan="1">160.18 (125.7&#8211;202.67)</td><td valign="top" align="left" rowspan="1" colspan="1">0.96% (0.83&#8211;1.09)</td><td valign="top" align="left" rowspan="1" colspan="1">0.89 (0.71&#8211;1.07)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">North Africa and the Middle East</td><td valign="top" align="left" rowspan="1" colspan="1">81,921.61 (64,667.39&#8211;104,296.2)</td><td valign="top" align="left" rowspan="1" colspan="1">79.91 (63.99&#8211;99.66)</td><td valign="top" align="left" rowspan="1" colspan="1">217,791.49 (171,790.55&#8211;275,028.53)</td><td valign="top" align="left" rowspan="1" colspan="1">81.61 (65.1&#8211;100.78)</td><td valign="top" align="left" rowspan="1" colspan="1">1.66% (1.43&#8211;2.05)</td><td valign="top" align="left" rowspan="1" colspan="1">0.01 (&#8722;0.01&#8211;0.04)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Oceania</td><td valign="top" align="left" rowspan="1" colspan="1">1,714.91 (1,278.28&#8211;2,249.71)</td><td valign="top" align="left" rowspan="1" colspan="1">109.88 (83.38&#8211;140.9)</td><td valign="top" align="left" rowspan="1" colspan="1">4,265.72 (3,269.65&#8211;5,477.39)</td><td valign="top" align="left" rowspan="1" colspan="1">116.58 (91.06&#8211;148.01)</td><td valign="top" align="left" rowspan="1" colspan="1">1.49% (1.26&#8211;1.74)</td><td valign="top" align="left" rowspan="1" colspan="1">0.23 (0.22&#8211;0.25)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">South Asia</td><td valign="top" align="left" rowspan="1" colspan="1">313,839.17 (233,856.25&#8211;415,086.12)</td><td valign="top" align="left" rowspan="1" colspan="1">96.83 (73.96&#8211;124.55)</td><td valign="top" align="left" rowspan="1" colspan="1">1,004,000.6 (767,638.51&#8211;1,284,863.5)</td><td valign="top" align="left" rowspan="1" colspan="1">106.05 (82.89&#8211;132.86)</td><td valign="top" align="left" rowspan="1" colspan="1">2.2% (1.83&#8211;2.62)</td><td valign="top" align="left" rowspan="1" colspan="1">0.26 (0.22&#8211;0.31)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Southeast Asia</td><td valign="top" align="left" rowspan="1" colspan="1">146,339.5 (109,111.94&#8211;193,284.06)</td><td valign="top" align="left" rowspan="1" colspan="1">95.11 (73.3&#8211;122.94)</td><td valign="top" align="left" rowspan="1" colspan="1">407,099.72 (309,292.37&#8211;534,122.36)</td><td valign="top" align="left" rowspan="1" colspan="1">105.7 (82.22&#8211;133.52)</td><td valign="top" align="left" rowspan="1" colspan="1">1.78% (1.59&#8211;2.01)</td><td valign="top" align="left" rowspan="1" colspan="1">0.37 (0.34&#8211;0.4)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Southern Latin America</td><td valign="top" align="left" rowspan="1" colspan="1">33,270.72 (27,276.91&#8211;41,107.45)</td><td valign="top" align="left" rowspan="1" colspan="1">96.08 (79.7&#8211;117.41)</td><td valign="top" align="left" rowspan="1" colspan="1">67,885.01 (55,648.18&#8211;84,703.48)</td><td valign="top" align="left" rowspan="1" colspan="1">100.95 (83.35&#8211;125.77)</td><td valign="top" align="left" rowspan="1" colspan="1">1.04% (0.92&#8211;1.17)</td><td valign="top" align="left" rowspan="1" colspan="1">0.18 (0.13&#8211;0.22)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Southern Sub-Saharan Africa</td><td valign="top" align="left" rowspan="1" colspan="1">12,289.22 (9,702.16&#8211;15,684.97)</td><td valign="top" align="left" rowspan="1" colspan="1">71.59 (58.23&#8211;88.42)</td><td valign="top" align="left" rowspan="1" colspan="1">27,739.42 (22,471.51&#8211;34,542.25)</td><td valign="top" align="left" rowspan="1" colspan="1">79.24 (65.78&#8211;95.69)</td><td valign="top" align="left" rowspan="1" colspan="1">1.26% (1.1&#8211;1.41)</td><td valign="top" align="left" rowspan="1" colspan="1">0.36 (0.24&#8211;0.48)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Tropical Latin America</td><td valign="top" align="left" rowspan="1" colspan="1">57,018.18 (46,603.14&#8211;71,324.15)</td><td valign="top" align="left" rowspan="1" colspan="1">98.38 (81.69&#8211;120.63)</td><td valign="top" align="left" rowspan="1" colspan="1">179,609.76 (147,086.35&#8211;221,530.81)</td><td valign="top" align="left" rowspan="1" colspan="1">102.34 (84.28&#8211;124.34)</td><td valign="top" align="left" rowspan="1" colspan="1">2.15% (1.86&#8211;2.3)</td><td valign="top" align="left" rowspan="1" colspan="1">0.52 (0.4&#8211;0.64)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Western Europe</td><td valign="top" align="left" rowspan="1" colspan="1">721,985.38 (571,968.84&#8211;930,654.64)</td><td valign="top" align="left" rowspan="1" colspan="1">144.62 (114.54&#8211;185.07)</td><td valign="top" align="left" rowspan="1" colspan="1">1,054,466.71 (845,195.76&#8211;1,323,431.16)</td><td valign="top" align="left" rowspan="1" colspan="1">132.81 (105.93&#8211;168.11)</td><td valign="top" align="left" rowspan="1" colspan="1">0.46% (0.32&#8211;0.56)</td><td valign="top" align="left" rowspan="1" colspan="1">&#8722;0.19 (&#8722;0.22 to &#8722;0.16)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Western Sub-Saharan Africa</td><td valign="top" align="left" rowspan="1" colspan="1">43,386.15 (33,451.62&#8211;54,984.95)</td><td valign="top" align="left" rowspan="1" colspan="1">82.99 (65.49&#8211;103.45)</td><td valign="top" align="left" rowspan="1" colspan="1">91,498.32 (73,641.02&#8211;111785.32)</td><td valign="top" align="left" rowspan="1" colspan="1">86.19 (70&#8211;103.25)</td><td valign="top" align="left" rowspan="1" colspan="1">1.11% (0.73&#8211;1.39)</td><td valign="top" align="left" rowspan="1" colspan="1">0.08 (0.05&#8211;0.1)</td></tr></tbody></table><table-wrap-foot><p>ASIR, age-standardized incidence rate; ASMR, age-standardized mortality rate; ASDR, age-standardized DALYs rate; EAPC, estimated annual percentage change; CI, confidence interval; UI, uncertainty interval.</p></table-wrap-foot></table-wrap><fig position="float" id="F1" orientation="portrait"><label>Figure 1</label><caption><p>The number of cases and ASRs of AF from 1990 to 2019. <bold>(A)</bold> The number of cases of AF caused by global, from 1990 to 2019. <bold>(B)</bold> The number of cases of AF caused by SDI regions from 1990 to 2019. <bold>(C)</bold> The ASRs of AF caused by SDI regions from 1990 to 2019. SDI, sociodemographic index.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fpubh-11-1137230-g0001.jpg"/></fig></sec><sec><title>Regional burden of AF</title><p>For SDI regions, the number of AF cases showed an upward trend in the five SDI countries from 2009 to 2019 (<xref rid="T1" ref-type="table">Table 1</xref>, <xref rid="F1" ref-type="fig">Figure 1B</xref>). Interestingly, the higher the SDI region, the higher the morbidity and mortality. From 1990 to 2019, the number of incidences and DALY cases of AF rose most dramatically in the middle SDI. However, the number of deaths increased most substantially in low-middle SDI (<xref rid="T1" ref-type="table">Table 1</xref>, <xref rid="F1" ref-type="fig">Figure 1B</xref>). Only high-middle SDI recorded a decreasing AF ASR, including ASIR (&#8722;0.12; 95% CI: &#8722;0.15 to &#8722;0.09), ASMR (&#8722;0.25; &#8722;0.32 to &#8722;0.18), and ASDR (&#8722;0.25; &#8722;0.28 to &#8722;0.23) of the EAPC (<xref rid="T1" ref-type="table">Table 1</xref>, <xref rid="F1" ref-type="fig">Figure 1C</xref>, <xref rid="SM1" ref-type="supplementary-material">Supplementary Figure 1</xref>). Regarding the rest of the 21 GBD regions, the highest ASIR due to AF has occurred in high-income North America [108.53 (87.59&#8211;131.44)] since 2019 (<xref rid="T1" ref-type="table">Table 1</xref>, <xref rid="SM2" ref-type="supplementary-material">Supplementary Figure 2A</xref>). Similarly, the ASMR and ASDR of AF for men and women in Australasia were 6.86 (5.45&#8211;8.33) and 168.28 (132.54&#8211;214.32), respectively, which placed Australia in the top rank for AF related-mortality in 2019 (<xref rid="T1" ref-type="table">Table 1</xref>, <xref rid="SM2" ref-type="supplementary-material">Supplementary Figures 2B</xref>, <xref rid="SM2" ref-type="supplementary-material">C</xref>). It is also worth noting that the most prominent increases in the ASIR and ASDR were in high-income North America. Additionally, the most significant increases in the ASMR were exhibited in Central Asia, followed by southern sub-Saharan Africa, Southeast Asia, and high-income North America. During the research period, the most pronounced decrease in the ASIR, ASMR, and ASDR was reported, all in high-income Asia Pacific (<xref rid="T1" ref-type="table">Table 1</xref>, <xref rid="SM3" ref-type="supplementary-material">Supplementary Figure 3</xref>).</p></sec><sec><title>National burden of AF</title><p>In 2019, China presented the highest morbidity [818,493 (562,871&#8211;1,128,695)], mortality [39,970 (33,722&#8211;46,387)], and DALYs [1,383,674 (1,047,540&#8211;1,802,516)]. Coincidentally, all three accounted for approximately a quarter of the global caseload (<xref rid="SM5" ref-type="supplementary-material">Supplementary Tables 1</xref>&#8211;<xref rid="SM7" ref-type="supplementary-material">3</xref>). The United States of America exhibited the highest ASIR [109.52 (88.97&#8211;131.92)]; Montenegro showed the highest ASMR [14.38 (11.31&#8211;19.38)] and ASDR [250.62 (205.82&#8211;313.72)]. Conversely, Bolivia (Plurinational State of) had the lowest ASIR [14.41 (10.71&#8211;18.68)]; Singapore had the lowest ASMR [1.97 (1.44&#8211;2.37)] and ASDR [51.94 (40.06&#8211;67.04)] owing to AF (<xref rid="SM5" ref-type="supplementary-material">Supplementary Tables 1</xref>&#8211;<xref rid="SM7" ref-type="supplementary-material">3</xref>, <xref rid="F2" ref-type="fig">Figure 2A</xref>). As for the percentage change, the most remarkable rise was in Qatar from 1990 to 2019, with a 7.91% increase in AF incidences; the most conspicuous rise was in Bahrain during the 30 years, with an 8.82% increase in deaths and a 6.51% increase in DALYs (<xref rid="SM5" ref-type="supplementary-material">Supplementary Tables 1</xref>&#8211;<xref rid="SM7" ref-type="supplementary-material">3</xref>, <xref rid="F2" ref-type="fig">Figure 2B</xref>). Furthermore, the most apparent increase in ASIR was in the United States of America [1.51 (1.07&#8211;1.95)] from 1990 to 2019; the most significant rise in ASMR was in Uzbekistan [4.58 (4.23&#8211;4.94)]; the most demonstrable increases in the ASDR were in Bahrain [2.71(2.27&#8211;3.14)] and Uzbekistan [2.32 (2.17&#8211;2.47)] (<xref rid="SM5" ref-type="supplementary-material">Supplementary Tables 1</xref>&#8211;<xref rid="SM7" ref-type="supplementary-material">3</xref>, <xref rid="F2" ref-type="fig">Figure 2C</xref>). By comparison, Japan displayed significant decreases in the ASIR and ASDR; Guam exhibited the most pronounced decline in the ASMR (<xref rid="SM5" ref-type="supplementary-material">Supplementary Tables 1</xref>&#8211;<xref rid="SM7" ref-type="supplementary-material">3</xref>, <xref rid="F2" ref-type="fig">Figure 2C</xref>).</p><fig position="float" id="F2" orientation="portrait"><label>Figure 2</label><caption><p>The national burden of AF for both sexes in 204 countries and territories. <bold>(A)</bold> The relative ASRs of AF between 1990 and 2019. <bold>(B)</bold> The relative changes of AF between 1990 and 2019. <bold>(C)</bold> The relative EAPCs of AF between 1990 and 2019.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fpubh-11-1137230-g0002.jpg"/></fig></sec><sec><title>The influential factors for EAPC</title><p><xref rid="F3" ref-type="fig">Figure 3</xref> shows that ASR (in 2019) and HDI (in 2019) seem to be particularly associated with EAPC. The ASMR of AF implies a healthy life expectancy from disease onset to eventual death. Meanwhile, HDI can be considered a metric to measure the accessibility and level of medical treatment. A significant positive relationship was observed between EAPCs and ASMR. Remarkably, a significant positive association was observed between EAPC and HDI when the HDI was restricted to &lt;0.6. However, when the HDI was above 0.6, the countries with a higher HDI experienced a sharper decrease in EAPC of atrial fibrillation from 1990 to 2019 (<xref rid="F3" ref-type="fig">Figure 3</xref>).</p><fig position="float" id="F3" orientation="portrait"><label>Figure 3</label><caption><p>The association between EAPC and ASMR in 2019 and HDI in 2019. <bold>(A)</bold> The association between EAPC and ASMR in 2019. <bold>(B)</bold> The association between EAPC and HDI in 2019. EAPC, estimated annual percentage change; ASMR, age-standardized mortality rate; HDI, human development index.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fpubh-11-1137230-g0003.jpg"/></fig></sec><sec><title>Relationship of ASRs with SDI</title><p>A non-linear association was investigated between SDI and ASIR in global and 21 regions. The highest ASIR was found in high-income North America, with an SDI of 0.86. The ASIR was lowest in the Andean-Latin America area when the SDI was 0.53. At the region level, the ASIR values of 10 areas based on SDI in 2019 were higher than the global level, consisting of high-income North America, Australasia, Central Europe, Eastern Europe, Western Europe, Central Asia, Southeast Asia, South Asia, Oceania, and East Asia (<xref rid="F4" ref-type="fig">Figure 4</xref>). The biggest ASMR and ASDR both appeared in Australasia, with SDI values of 0.77 and 0.74, respectively.</p><fig position="float" id="F4" orientation="portrait"><label>Figure 4</label><caption><p>ASIR of AF in the global and 21 regions by SDI, 1990&#8211;2019. ASIR, age-standardized incidence rate; SDI, sociodemographic index.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fpubh-11-1137230-g0004.jpg"/></fig><p>At the national level, we explored the relationship between ASIR and SDI values, which were complex and non-linear in 2019. Further analysis revealed that the ASIR in 204 countries and territories was positively correlated with the SDI. The largest ASIR was in the United States of America, followed by Canada and Greenland, according to the SDI. The ASIR was larger than the anticipated level in a number of territories. Nevertheless, Bolivia (the Plurinational State of), Peru, Ecuador, Eritrea, Somalia, and numerous other countries held a smaller ASIR than the expected SDI (<xref rid="F5" ref-type="fig">Figure 5</xref>). Non-linear relationships among the SDI, ASMR, and ASDR of atrial fibrillation were also surveyed. The highest ASMR and ASDR were both noted in Montenegro when the SDI value was 0.79. However, the lowest ASMR and ASDR occurred in Singapore, with an SDI value of 0.86. And the majority of countries had lower ASMR and ASDR levels than expected, such as Japan, Kuwait, and the Republic of Korea. Intriguingly, burden estimates experienced an upward trend with increasing SDI, yet ASDR had a higher rise than ASMR (<xref rid="SM4" ref-type="supplementary-material">Supplementary Figures 4A</xref>, <xref rid="SM4" ref-type="supplementary-material">B</xref>).</p><fig position="float" id="F5" orientation="portrait"><label>Figure 5</label><caption><p>ASIR of AF in 204 countries by SDI, 1990&#8211;2019. ASIR, age-standardized incidence rate; SDI, sociodemographic index.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fpubh-11-1137230-g0005.jpg"/></fig></sec><sec><title>Risk factors for AF</title><p>Globally, 219,437 (190,526&#8211;249,642) individuals have died from AF. The mortality of AF in 2019 may be attributed to the referring risk factors evaluated by GBD: alcohol use, behavioral risks, a diet high in sodium, a high body mass index (BMI), high systolic blood pressure (SBP), lead exposure, metabolic risks, and smoking. Among them, the two main risk factors were a high BMI and a high SBP. The above risk factors displayed different percentages depending on the sexes at the regional level. For instance, the highest percentage of deaths due to smoking was detected in Central Europe, 52% for males. Simultaneously, the lowest percentage of deaths due to smoking was in High-income Asia Pacific, with 36% for females. In Central Europe, men (37%) and women (14%) had the highest mortality rates due to behavioral risks. Regarding high systolic blood pressure (SBP), the highest proportion of deaths occurred in southern sub-Saharan Africa (men, 41%; women, 43%) (<xref rid="F6" ref-type="fig">Figure 6</xref>).</p><fig position="float" id="F6" orientation="portrait"><label>Figure 6</label><caption><p>The age-standardized deaths are attributable to the risk factors.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fpubh-11-1137230-g0006.jpg"/></fig></sec></sec><sec sec-type="discussion" id="s4"><title>Discussion</title><p>This is the first study to estimate the global burden and trends of AF in older adults aged 60&#8211;89 years and to recognize the associated risk factors. The results indicated that the burden of AF is gradually increasing globally, with an ~1.1-fold increase in incidences and an ~1.4-fold increase in deaths from 1990 to 2019. It may be attributable to improved survival with chronic diseases and the global population rising and aging (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B14" ref-type="bibr">14</xref>). Moreover, the ASIR was higher in high-income North America, Australasia, Eastern Europe, and Central Europe; it was lower in Andean-Latin America, Eastern Sub-Saharan Africa, and high-income Asia Pacific, which was in accordance with the prevalence of AF (<xref rid="B13" ref-type="bibr">13</xref>). However, it was worth noting that the rate of increase in the prevalence of AF was extraordinarily rapid in high-income North America and surrounding areas. This observation may be due to the rapidly evolving regional economy, the Westernization tendency of personal diet, and the higher morbidity of cardiovascular problems and metabolic disorders (<xref rid="B15" ref-type="bibr">15</xref>).</p><p>Our findings also revealed that the degree of disease burden in AF differed between men and women. In general, the number of incident cases was higher in women, but the result of the age-standardized incidence rate was completely opposite, which was consistent with the perspectives of IHME (<xref rid="B16" ref-type="bibr">16</xref>). It may be related to our selection of older adults aged 60&#8211;89 years as our research subjects. An original research article demonstrated that the incidence rate of AF in women has increased significantly since the age of 60 (<xref rid="B10" ref-type="bibr">10</xref>). Longevity in women may be another reason for the increased morbidity of AF (<xref rid="B10" ref-type="bibr">10</xref>).</p><p>Furthermore, several studies have been conducted to show that estrogen plays a protective role against AF by prolonging the effective refractory period and reducing atrial pressure, which could profoundly interpret the increase in susceptibility to AF in post-menopausal women (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B18" ref-type="bibr">18</xref>). Andrade et al. also observed a higher prevalence of age-adjusted AF in men than in women (<xref rid="B19" ref-type="bibr">19</xref>), which may be partially explained by the lower lifetime risk of AF in women (<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B21" ref-type="bibr">21</xref>). As for mortality, female patients with AF had a higher mortality rate, which may be due to the risk of thromboembolism (<xref rid="B22" ref-type="bibr">22</xref>). Previous studies have found female gender to be a major independent risk factor for thromboembolism in patients with AF (<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B24" ref-type="bibr">24</xref>).</p><p>At the global level, the values of ASIR and ASDR were far higher than ASMR. Patients with AF were at higher risk for concurrent stroke, heart failure, hypertension, and other cardiovascular diseases than those without arrhythmias (<xref rid="B25" ref-type="bibr">25</xref>). In clinical practice, complications and co-morbidities have been documented as the leading cause of death in patients with AF (<xref rid="B26" ref-type="bibr">26</xref>). As a result, the actual number of deaths caused by AF may be hard to count, and the estimated disease burden of AF-related deaths is lower than the actual number of deaths. Our analysis also revealed characteristics in incidence, mortality rates, and DALYs in distinct SDI territories. In 2019, both morbidity and mortality were highest in high SDI regions, while the lowest morbidity and mortality occurred in low SDI and middle SDI regions, respectively. However, the most dramatic growth can be discerned in the low and low-middle SDI regions. From 1990 to 2019, ASIR, ASMR, and ASDR showed a decreasing trend in both high SDI and high-moderate SDI quintiles. In addition, the results reflected that the ASIR, ASMR, and ASDR were positively correlated with SDI, which signified that the higher the SDI region, the higher the burden of disease in older adults. These findings were roughly consistent with the research of other scholars (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B27" ref-type="bibr">27</xref>). Groups with higher access to health care, educational qualifications, and greater health awareness would focus more on their health (<xref rid="B28" ref-type="bibr">28</xref>&#8211;<xref rid="B30" ref-type="bibr">30</xref>). Therefore, AF was more likely to be discovered and reported in areas with a higher SDI. The effective and proven tactics used to manage the burden associated with AF in high SDI regions, such as the United States of America, may serve as a valuable source of policy inspiration for other regions with relatively low SDI quintiles.</p><p>Furthermore, we explored the association between ASMR, EAPC, and HDI. HDI is a meaningful indicator to evaluate the level of national social and economic development (<xref rid="B31" ref-type="bibr">31</xref>). There was an inverted U-shaped relationship diagram: mid-HDI regions had a higher EAPC of deaths than high-HDI regions. It implied that the ASMR of AF in high HDI areas experienced a decrease while low HDI areas experienced an increase. This may be attributed to the more powerful medical and health services, higher resource allocation, and residents' more aggressive attitude to prevent and treat AF and its complications (<xref rid="B32" ref-type="bibr">32</xref>). It was clear from the current study that the disease burden of AF is an urgent concern and an issue that needs to be addressed in less economically developed regions at present and in the future. Hence, it was imperative to establish health- and economic-based AF prevention initiatives for relevant national departments and regional health authorities.</p><p>Eventually, we explored the influencing risk factors of AF in older adults based on the GBD database, involving alcohol use, smoking, a diet high in sodium, a high BMI, a high SBP, lead exposure, and metabolic risks. The relationship between AF and the first six risk factors has already been identified (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B33" ref-type="bibr">33</xref>). Our analysis confirmed that high SBP and high BMI were principal considerations in the burden of AF. Credible evidence has demonstrated that high blood pressure (HBP) is an independent risk element for AF (<xref rid="B34" ref-type="bibr">34</xref>&#8211;<xref rid="B36" ref-type="bibr">36</xref>). A systematic review showed a 50% higher relative risk of AF in patients with HBP compared to those without HBP (<xref rid="B37" ref-type="bibr">37</xref>). Each 20 mm Hg increase in systolic blood pressure was associated with a 19% corresponding increase in the risk of atrial fibrillation (<xref rid="B38" ref-type="bibr">38</xref>). A few clinical mechanisms might account for the elevated risk of AF in people with HBP. Higher blood pressure leads to an increased risk of coronary artery disease and myocardial infarction (<xref rid="B39" ref-type="bibr">39</xref>), which can induce AF (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B41" ref-type="bibr">41</xref>). Predictable epidemiological findings have demonstrated that increased blood pressure triggers inflammation in myocardial cells, contributing to fibrillation and an enlarged left ventricle (<xref rid="B42" ref-type="bibr">42</xref>, <xref rid="B43" ref-type="bibr">43</xref>), which in turn raises the risk of suffering from AF (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B44" ref-type="bibr">44</xref>).</p><p>Furthermore, chronic hypertensive patients may experience impaired left ventricular hypertrophy and left ventricular contraction-diastolic function, which increase atrial pressure and eventually worsen atrial contraction (<xref rid="B45" ref-type="bibr">45</xref>). Experts believe controlling blood pressure within the normal range is conducive to reducing the occurrence of AF (<xref rid="B46" ref-type="bibr">46</xref>, <xref rid="B47" ref-type="bibr">47</xref>). It is essential to adopt a low-salt diet and engage in home self-monitoring of blood pressure in daily life to prevent the occurrence of hypertension. High SBP and AF often co-exist, and the effect of obesity on AF should not be ignored. A former report highlighted that obesity elevated the risk of AF occurring by ~50% (<xref rid="B48" ref-type="bibr">48</xref>). Moreover, every 1 kg/m<sup>2</sup> higher BMI was correlated with a 6% increase in risk (<xref rid="B49" ref-type="bibr">49</xref>), which was perceived as an independent predictor of incident AF (<xref rid="B48" ref-type="bibr">48</xref>, <xref rid="B50" ref-type="bibr">50</xref>). Obesity exerted a proximate effect on cardiac muscle structure through enhanced exposure to oxidative strain (<xref rid="B51" ref-type="bibr">51</xref>). AF may be caused by electroanatomic remodeling in patients with a high BMI (<xref rid="B52" ref-type="bibr">52</xref>). Additionally, the role of BMI in generating the incidence of AF changed as age advanced. After the age of 60, alterations in physical components, such as increased fat mass and redistribution, may explain the increased influence of a high BMI on the risk of AF with age (<xref rid="B53" ref-type="bibr">53</xref>). As for the prognosis for patients with AF, a high BMI would increase the recurrence rate of AF (<xref rid="B54" ref-type="bibr">54</xref>) and the risk of paroxysmal atrial fibrillation developing into permanent atrial fibrillation (<xref rid="B55" ref-type="bibr">55</xref>). Therefore, weight control and physical exercise play a positive role in improving the prognosis and preventing the worsening of AF. In the future, both doctors and heart specialists are expected to incorporate recommendations on diet and lifestyle improvements, especially for obese older adults, into regular medical care. Moreover, metabolic syndrome may increase susceptibility to AF by activating significant oxidative stress signaling pathways and an inflammatory response (<xref rid="B56" ref-type="bibr">56</xref>). Metabolic syndrome is a kind of cardiovascular and metabolic disease that includes elevated blood pressure, overweight, hyperlipidemia, and insulin resistance (<xref rid="B57" ref-type="bibr">57</xref>). In the section above, we described the effects of high SBP and high BMI on AF, which contributed most to the increased risk of AF among the components of the metabolic syndrome (<xref rid="B58" ref-type="bibr">58</xref>). Considering the important impact of the metabolic syndrome on AF, a low-fat, low-sugar diet and regular monitoring of blood glucose and lipids are essential for formulating targeted AF prevention strategies in older adults. Additionally, we can create prevention and monitoring precautions according to the risk factors in different regions and by gender. For example, South Asia has higher mortality rates due to lead exposure than other regions, so avoiding lead exposure and reducing environmental lead concentrations could be used for AF prevention in South Asia. It was worth mentioning that the attribution proportions for smoking and alcohol consumption were significantly higher for men than for women. For men, quitting smoking and limiting alcohol to prevent the occurrence of AF should be valued.</p><p>Based on the findings above, we can conclude that our research is valuable in developing a worldwide strategy for effectively for screening AF in certain groups. More precisely, screening programs targeting risk factors are more effective. First, we should pay special attention to the older female population. Regular electrocardiogram examinations are necessary for them. Second, high SBP and high BMI have the greatest impact on AF. Thus, blood pressure and weight measurements must be included in the screening programs. Finally, we can establish screening plans for other risk factors. Smoking, alcohol consumption, a high-salt diet, and chronic lead exposure are key populations for AF screening, especially in males. In other words, high-risk individuals with AF need to undergo regular medical check-ups in specialized medical institutions with the goal of early screening, timely treatment planning, and delaying the progression of AF.</p><p>The current study has several limitations. First, our analysis was impacted by deficiencies in the 2019 GBD study methodology, which have been documented in previous literature (<xref rid="B59" ref-type="bibr">59</xref>&#8211;<xref rid="B61" ref-type="bibr">61</xref>). Insufficient and untimely registration of AF in some underdeveloped regions resulted in the underestimation of patients as well as misdiagnosis or under diagnosis owing to the lack of adequate medical resources. Overall, the data from some countries were not integral, which affected the precision and reliability of the results. Second, the GBD research did not meticulously classify AF into first-diagnosed AF, paroxysmal AF, persistent AF, and so on, based on clinical characteristics. Third, other pathological factors, such as rheumatic heart disease, hyperthyroidism, and pre-excitation syndrome, were not considered. Finally, the outbreak and prevalence of COVID-19 have had a serious impact on the burden of AF (<xref rid="B62" ref-type="bibr">62</xref>), and more evidence is urgently needed to compare changes in AF during the epidemic.</p></sec><sec sec-type="conclusions" id="s5"><title>Conclusion</title><p>In conclusion, AF in older adults is a major public health concern worldwide. The burden of AF varies widely at both national and regional levels. From 1990 to 2019, the cases of AF incidences, deaths, and DALYs have shown a global increase. The ASIR, ASMR, and ASDR have declined in the high-moderate and high SDI regions. However, the burden of AF increased promptly in the lower SDI regions. Moreover, it is necessary to consider the predominant risk factors for AF, such as high BMI and SBP, to encourage individuals with a high risk of AF to perform health management and early screening. By interpreting the burden of AF at different regional and national levels, our research illustrates the features of the global AF burden in pursuit of more effective and targeted prevention and treatment strategies.</p></sec><sec sec-type="data-availability" id="s6"><title>Data availability statement</title><p>The original contributions presented in the study are included in the article/<xref rid="s9" ref-type="sec">Supplementary material</xref>, further inquiries can be directed to the corresponding authors.</p></sec><sec sec-type="author-contributions" id="s7"><title>Author contributions</title><p>MJ, CL, and QG conducted a statistical analysis of the data. MJ drafted the manuscript. AM and QG conceptualized and designed the research and revised the manuscript. YL and YW collected and sorted the data. All authors contributed to the article and approved the submitted version.</p></sec></body><back><sec sec-type="COI-statement" id="conf1"><title>Conflict of interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type="disclaimer" id="s8"><title>Publisher's note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><sec sec-type="supplementary-material" id="s9"><title>Supplementary material</title><p>The Supplementary Material for this article can be found online at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.frontiersin.org/articles/10.3389/fpubh.2023.1137230/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fpubh.2023.1137230/full#supplementary-material</ext-link></p><supplementary-material id="SM1" position="float" content-type="local-data" orientation="portrait"><label>Supplementary Figure 1</label><caption><p>The EAPCs of AF ASRs from 1990 to 2019, both sexes by SDI. SDI, sociodemographic index.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Image_1.TIF" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="SM2" position="float" content-type="local-data" orientation="portrait"><label>Supplementary Figure 2</label><caption><p>The regional burden of AF for both sexes in 2019. <bold>(A)</bold> ASIR in regions, 1990&#8211;2019; <bold>(B)</bold> ASMR in regions, 1990&#8211;2019; <bold>(C)</bold> ASDR in regions, 1990&#8211;2019. ASIR, age-standardized incidence rate; ASMR, age-standardized mortality rate; ASDR, age-standardized DALYs rate.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Image_2.TIF" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="SM3" position="float" content-type="local-data" orientation="portrait"><label>Supplementary Figure 3</label><caption><p>The EAPCs of AF at the regional level, from 1990 to 2019.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Image_3.TIF" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="SM4" position="float" content-type="local-data" orientation="portrait"><label>Supplementary Figure 4</label><caption><p>ASRs of AF in 204 countries by SDI, 1990&#8211;2019. <bold>(A)</bold> ASMR in 204 countries and territories, 2019; <bold>(B)</bold> ASDR in 204 countries and territories, 2019. ASMR, age-standardized mortality rate; ASDR, age-standardized DALYs rate; SDI, sociodemographic index.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Image_4.TIF" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="SM5" position="float" content-type="local-data" orientation="portrait"><label>Supplementary Table 1</label><caption><p>The incidence of atrial fibrillation between 1990 and 2019 at national level.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Table_1.DOCX" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="SM6" position="float" content-type="local-data" orientation="portrait"><label>Supplementary Table 2</label><caption><p>The deaths of atrial fibrillation between 1990 and 2019 at national level.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Table_2.DOCX" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material id="SM7" position="float" content-type="local-data" orientation="portrait"><label>Supplementary Table 3</label><caption><p>The disability-adjusted life years (DALYs) of atrial fibrillation between 1990 and 2019 at national level.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Table_3.DOCX" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec><ref-list><title>References</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fang</surname><given-names>MC</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Rich</surname><given-names>MW</given-names></name></person-group>. <article-title>Atrial fibrillation in the older adults</article-title>. <source>Am J Med.</source> (<year>2007</year>) <volume>120</volume>:<fpage>481</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.amjmed.2007.01.026</pub-id><pub-id pub-id-type="pmid">17524745</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roth</surname><given-names>GA</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>C</given-names></name><name name-style="western"><surname>Abajobir</surname><given-names>A</given-names></name><name name-style="western"><surname>Abd-Allah</surname><given-names>F</given-names></name><name name-style="western"><surname>Abera</surname><given-names>SF</given-names></name><name name-style="western"><surname>Abyu</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015</article-title>. <source>J Am Coll Cardiol.</source> (<year>2017</year>) <volume>70</volume>:<fpage>1</fpage>&#8211;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2017.04.052</pub-id><pub-id pub-id-type="pmid">28527533</pub-id><pub-id pub-id-type="pmcid">PMC5491406</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guez</surname><given-names>D</given-names></name><name name-style="western"><surname>Boroumand</surname><given-names>G</given-names></name><name name-style="western"><surname>Ruggiero</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Mehrotra</surname><given-names>P</given-names></name><name name-style="western"><surname>Halpern</surname><given-names>EJ</given-names></name></person-group>. <article-title>Automated and manual measurements of the aortic annulus with ECG-gated cardiac CT angiography prior to transcatheter aortic valve replacement: Comparison with 3D-transesophageal echocardiography</article-title>. <source>Acad Radiol.</source> (<year>2017</year>) <volume>24</volume>:<fpage>587</fpage>&#8211;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.acra.2016.12.008</pub-id><pub-id pub-id-type="pmid">28130049</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schnabel</surname><given-names>RB</given-names></name><name name-style="western"><surname>Yin</surname><given-names>X</given-names></name><name name-style="western"><surname>Gona</surname><given-names>P</given-names></name><name name-style="western"><surname>Larson</surname><given-names>MG</given-names></name><name name-style="western"><surname>Beiser</surname><given-names>AS</given-names></name><name name-style="western"><surname>McManus</surname><given-names>DD</given-names></name><etal/></person-group>. <article-title>50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: A cohort study</article-title>. <source>Lancet.</source> (<year>2015</year>) <volume>386</volume>:<fpage>154</fpage>&#8211;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(14)61774-8</pub-id><pub-id pub-id-type="pmid">25960110</pub-id><pub-id pub-id-type="pmcid">PMC4553037</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lippi</surname><given-names>G</given-names></name><name name-style="western"><surname>Sanchis-Gomar</surname><given-names>F</given-names></name><name name-style="western"><surname>Cervellin</surname><given-names>G</given-names></name></person-group>. <article-title>Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge</article-title>. <source>Int J Stroke.</source> (<year>2021</year>) <volume>16</volume>:<fpage>217</fpage>&#8211;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1177/1747493019897870</pub-id><pub-id pub-id-type="pmid">31955707</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murray</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Lopez</surname><given-names>AD</given-names></name></person-group>. <article-title>Measuring the globalburden of disease</article-title>. <source>N Engl J Med.</source> (<year>2013</year>) <volume>369</volume>:<fpage>448</fpage>&#8211;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra1201534</pub-id><pub-id pub-id-type="pmid">23902484</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Ze</surname><given-names>F</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Mi</surname><given-names>L</given-names></name><name name-style="western"><surname>Han</surname><given-names>B</given-names></name><name name-style="western"><surname>Niu</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Trends of global burden of atrial fibrillation/flutter from Global Burden of Disease Study 2017</article-title>. <source>Heart.</source> (<year>2021</year>) <volume>107</volume>:<fpage>881</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1136/heartjnl-2020-317656</pub-id><pub-id pub-id-type="pmid">33148545</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Song</surname><given-names>X</given-names></name><name name-style="western"><surname>Liang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Bai</surname><given-names>X</given-names></name><name name-style="western"><surname>Liu-Huo</surname><given-names>WS</given-names></name><name name-style="western"><surname>Tang</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Global, regional, and national burden of disease study of atrial fibrillation/flutter, 1990-2019: Results from a global burden of disease study, 2019</article-title>. <source>BMC Public Health.</source> (<year>2022</year>) <volume>22</volume>:<fpage>2015</fpage>. <pub-id pub-id-type="doi">10.1186/s12889-022-14403-2</pub-id><pub-id pub-id-type="pmid">36329400</pub-id><pub-id pub-id-type="pmcid">PMC9632152</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Osorio</surname><given-names>J</given-names></name><name name-style="western"><surname>Mansour</surname><given-names>M</given-names></name><name name-style="western"><surname>Melby</surname><given-names>D</given-names></name><name name-style="western"><surname>Imhoff</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Hunter</surname><given-names>TD</given-names></name><name name-style="western"><surname>Maccioni</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Economic evaluation of contact force catheter ablation for persistent atrial fibrillation in the United States</article-title>. <source>Heart Rhythm O</source><sub>2</sub>. (<year>2022</year>) <volume>3</volume>:<fpage>647</fpage>&#8211;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/j.hroo.2022.09.011</pub-id><pub-id pub-id-type="pmid">36589917</pub-id><pub-id pub-id-type="pmcid">PMC9795304</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Magnussen</surname><given-names>C</given-names></name><name name-style="western"><surname>Niiranen</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Ojeda</surname><given-names>FM</given-names></name><name name-style="western"><surname>Gianfagna</surname><given-names>F</given-names></name><name name-style="western"><surname>Blankenberg</surname><given-names>S</given-names></name><name name-style="western"><surname>Nj&#248;lstad</surname><given-names>I</given-names></name><etal/></person-group>. <article-title>Sex differences and similarities in atrial fibrillation epidemiology, risk factors, and mortality in community cohorts: Results from the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe)</article-title>. <source>Circulation.</source> (<year>2017</year>) <volume>136</volume>:<fpage>1588</fpage>&#8211;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.117.028981</pub-id><pub-id pub-id-type="pmid">29038167</pub-id><pub-id pub-id-type="pmcid">PMC5657474</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="webpage"><person-group person-group-type="author"><collab>Global Burden of Disease Collaborative Network</collab></person-group>. <article-title>Global Burden ofDisease Study 2016 (GBD 2016) Results</article-title>. Seattle, United States: Institutefor Health Metrics and Evaluation (IHME) (<year>2017</year>). Available from <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://ghdx.healthdata.org/gbd-results-tool" ext-link-type="uri">http://ghdx.healthdata.org/gbd-results-tool</ext-link>.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>H</given-names></name><name name-style="western"><surname>Fang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Cai</surname><given-names>N</given-names></name><name name-style="western"><surname>Suo</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention</article-title>. <source>J Hepatol.</source> (<year>2019</year>) <volume>70</volume>:<fpage>674</fpage>&#8211;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/j.jhep.2018.12.001</pub-id><pub-id pub-id-type="pmid">30543829</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chugh</surname><given-names>SS</given-names></name><name name-style="western"><surname>Havmoeller</surname><given-names>R</given-names></name><name name-style="western"><surname>Narayanan</surname><given-names>K</given-names></name><name name-style="western"><surname>Singh</surname><given-names>D</given-names></name><name name-style="western"><surname>Rienstra</surname><given-names>M</given-names></name><name name-style="western"><surname>Benjamin</surname><given-names>EJ</given-names></name><etal/></person-group>. <article-title>Worldwide epidemiology of atrial fibrillation: A Global Burden of Disease 2010 Study</article-title>. <source>Circulation.</source> (<year>2014</year>) <volume>129</volume>:<fpage>837</fpage>&#8211;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.113.005119</pub-id><pub-id pub-id-type="pmid">24345399</pub-id><pub-id pub-id-type="pmcid">PMC4151302</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fordyce</surname><given-names>CB</given-names></name><name name-style="western"><surname>Roe</surname><given-names>MT</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>T</given-names></name><name name-style="western"><surname>Libby</surname><given-names>P</given-names></name><name name-style="western"><surname>Borer</surname><given-names>JS</given-names></name><name name-style="western"><surname>Hiatt</surname><given-names>WR</given-names></name><etal/></person-group>. <article-title>Cardiovascular drug development: Is it dead or just hibernating?</article-title><source>J Am Coll Cardiol.</source> (<year>2015</year>) <volume>65</volume>:<fpage>1567</fpage>&#8211;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2015.03.016</pub-id><pub-id pub-id-type="pmid">25881939</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bhagavathula</surname><given-names>AS</given-names></name><name name-style="western"><surname>Shehab</surname><given-names>A</given-names></name><name name-style="western"><surname>Ullah</surname><given-names>A</given-names></name><name name-style="western"><surname>Rahmani</surname><given-names>J</given-names></name></person-group>. <article-title>The burden of cardiovascular disease risk factors in the Middle East: A systematic review and Meta-analysis focusing on primary prevention</article-title>. <source>Curr Vasc Pharmacol.</source> (<year>2021</year>) <volume>19</volume>:<fpage>379</fpage>&#8211;<lpage>89</lpage>. <pub-id pub-id-type="doi">10.2174/1573406416666200611104143</pub-id><pub-id pub-id-type="pmid">32525775</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="webpage"><person-group person-group-type="author"><collab>Institute for Health Metrics Evaluation. GBD Compare Data Visualization. Seattle, WA: IHME, University of Washington</collab></person-group> (<year>2018</year>). Available online at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://vizhub.healthdata.org/gbd-compare" ext-link-type="uri">http://vizhub.healthdata.org/gbd-compare</ext-link> (accessed June 3, 2020).</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tse</surname><given-names>HF</given-names></name><name name-style="western"><surname>Oral</surname><given-names>H</given-names></name><name name-style="western"><surname>Pelosi</surname><given-names>F</given-names></name><name name-style="western"><surname>Knight</surname><given-names>BP</given-names></name><name name-style="western"><surname>Strickberger</surname><given-names>SA</given-names></name><name name-style="western"><surname>Morady</surname><given-names>F</given-names></name></person-group>. <article-title>Effect of gender on atrial electrophysiologic changes induced by rapid atrial pacing and elevation of atrial pressure</article-title>. <source>J Cardiovasc Electrophysiol.</source> (<year>2001</year>) <volume>12</volume>:<fpage>986</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1046/j.1540-8167.2001.00986.x</pub-id><pub-id pub-id-type="pmid">11573707</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Westerman</surname><given-names>S</given-names></name><name name-style="western"><surname>Wenger</surname><given-names>N</given-names></name></person-group>. <article-title>Gender differences in atrial fibrillation: A review of epidemiology, management, and outcomes</article-title>. <source>Curr Cardiol Rev.</source> (<year>2019</year>) <volume>15</volume>:<fpage>136</fpage>&#8211;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.2174/1573403X15666181205110624</pub-id><pub-id pub-id-type="pmid">30516110</pub-id><pub-id pub-id-type="pmcid">PMC6520576</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andrade</surname><given-names>JG</given-names></name><name name-style="western"><surname>Deyell</surname><given-names>MW</given-names></name><name name-style="western"><surname>Lee</surname><given-names>AYK</given-names></name><name name-style="western"><surname>Macle</surname><given-names>L</given-names></name></person-group>. <article-title>Sex differences in atrial fibrillation</article-title>. <source>Can J Cardiol.</source> (<year>2018</year>) <volume>34</volume>:<fpage>429</fpage>&#8211;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/j.cjca.2017.11.022</pub-id><pub-id pub-id-type="pmid">29455950</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ko</surname><given-names>D</given-names></name><name name-style="western"><surname>Rahman</surname><given-names>F</given-names></name><name name-style="western"><surname>Schnabel</surname><given-names>RB</given-names></name><name name-style="western"><surname>Yin</surname><given-names>X</given-names></name><name name-style="western"><surname>Benjamin</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Christophersen</surname><given-names>IE</given-names></name></person-group>. <article-title>Atrial fibrillation in women: Epidemiology, pathophysiology, presentation, and prognosis</article-title>. <source>Nat Rev Cardiol.</source> (<year>2016</year>) <volume>13</volume>:<fpage>321</fpage>&#8211;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1038/nrcardio.2016.45</pub-id><pub-id pub-id-type="pmid">27053455</pub-id><pub-id pub-id-type="pmcid">PMC5579870</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alonso</surname><given-names>A</given-names></name><name name-style="western"><surname>Agarwal</surname><given-names>SK</given-names></name><name name-style="western"><surname>Soliman</surname><given-names>EZ</given-names></name><name name-style="western"><surname>Ambrose</surname><given-names>M</given-names></name><name name-style="western"><surname>Chamberlain</surname><given-names>AM</given-names></name><name name-style="western"><surname>Prineas</surname><given-names>RJ</given-names></name><etal/></person-group>. <article-title>Incidence of atrial fibrillation in whites and African-Americans: The Atherosclerosis Risk in Communities (ARIC) study</article-title>. <source>Am Heart J.</source> (<year>2009</year>) <volume>158</volume>:<fpage>111</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.ahj.2009.05.010</pub-id><pub-id pub-id-type="pmid">19540400</pub-id><pub-id pub-id-type="pmcid">PMC2720573</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Johnsen</surname><given-names>SP</given-names></name><name name-style="western"><surname>Guo</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lip</surname><given-names>GYH</given-names></name></person-group>. <article-title>Epidemiology of atrial fibrillation: Geographic/ecological risk factors, age, sex, genetics</article-title>. <source>Card Electrophysiol Clin.</source> (<year>2021</year>) <volume>13</volume>:<fpage>1</fpage>&#8211;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccep.2020.10.010</pub-id><pub-id pub-id-type="pmid">33516388</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fang</surname><given-names>MC</given-names></name><name name-style="western"><surname>Singer</surname><given-names>DE</given-names></name><name name-style="western"><surname>Chang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hylek</surname><given-names>EM</given-names></name><name name-style="western"><surname>Henault</surname><given-names>LE</given-names></name><name name-style="western"><surname>Jensvold</surname><given-names>NG</given-names></name><etal/></person-group>. <article-title>Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and risk factors in atrial fibrillation (ATRIA) study</article-title>. <source>Circulation.</source> (<year>2005</year>) <volume>112</volume>:<fpage>1687</fpage>&#8211;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.105.553438</pub-id><pub-id pub-id-type="pmid">16157766</pub-id><pub-id pub-id-type="pmcid">PMC3522521</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lip</surname><given-names>GYH</given-names></name><name name-style="western"><surname>Nieuwlaat</surname><given-names>R</given-names></name><name name-style="western"><surname>Pisters</surname><given-names>R</given-names></name><name name-style="western"><surname>Lane</surname><given-names>DA</given-names></name><name name-style="western"><surname>Crijns</surname><given-names>HJGM</given-names></name></person-group>. <article-title>Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation</article-title>. <source>Chest.</source> (<year>2010</year>) <volume>137</volume>:<fpage>263</fpage>&#8211;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1378/chest.09-1584</pub-id><pub-id pub-id-type="pmid">19762550</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Virani</surname><given-names>SS</given-names></name><name name-style="western"><surname>Alonso</surname><given-names>A</given-names></name><name name-style="western"><surname>Benjamin</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Bittencourt</surname><given-names>MS</given-names></name><name name-style="western"><surname>Callaway</surname><given-names>CW</given-names></name><name name-style="western"><surname>Carson</surname><given-names>AP</given-names></name><etal/></person-group>. <article-title>Heart disease and stroke statistics-2020 update: A report from the American Heart Association</article-title>. <source>Circulation.</source> (<year>2020</year>) <volume>141</volume>:<fpage>e139</fpage>&#8211;<lpage>596</lpage>. <pub-id pub-id-type="doi">10.1161/CIR.0000000000000757</pub-id><pub-id pub-id-type="pmid">31992061</pub-id></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deshpande</surname><given-names>S</given-names></name><name name-style="western"><surname>Catanzaro</surname><given-names>J</given-names></name><name name-style="western"><surname>Wann</surname><given-names>S</given-names></name></person-group>. <article-title>Atrial fibrillation: Prevalence and scope of the problem</article-title>. <source>Card Electrophysiol Clin.</source> (<year>2014</year>) <volume>6</volume>:<fpage>1</fpage>&#8211;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccep.2013.10.006</pub-id><pub-id pub-id-type="pmid">27063816</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Freedman</surname><given-names>B</given-names></name><name name-style="western"><surname>Hindricks</surname><given-names>G</given-names></name><name name-style="western"><surname>Banerjee</surname><given-names>A</given-names></name><name name-style="western"><surname>Baranchuk</surname><given-names>A</given-names></name><name name-style="western"><surname>Ching</surname><given-names>CK</given-names></name><name name-style="western"><surname>Du</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>World heart federation roadmap on atrial fibrillation&#8212;A 2020 update</article-title>. <source>Glob Heart.</source> (<year>2021</year>) <volume>16</volume>:<fpage>41</fpage>. <pub-id pub-id-type="doi">10.5334/gh.1023</pub-id><pub-id pub-id-type="pmid">34211827</pub-id><pub-id pub-id-type="pmcid">PMC8162289</pub-id></mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Su</surname><given-names>D</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Effect of socioeconomic status on the physical and mental health of the older adults: The mediating effect of social participation</article-title>. <source>BMC Public Health.</source> (<year>2022</year>) <volume>22</volume>:<fpage>605</fpage>. <pub-id pub-id-type="doi">10.1186/s12889-022-13062-7</pub-id><pub-id pub-id-type="pmid">35351078</pub-id><pub-id pub-id-type="pmcid">PMC8962021</pub-id></mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>L&#246;vd&#233;n</surname><given-names>M</given-names></name><name name-style="western"><surname>Fratiglioni</surname><given-names>L</given-names></name><name name-style="western"><surname>Glymour</surname><given-names>MM</given-names></name><name name-style="western"><surname>Lindenberger</surname><given-names>U</given-names></name><name name-style="western"><surname>Tucker-Drob</surname><given-names>EM</given-names></name></person-group>. <article-title>Education and cognitive functioning across the life span</article-title>. <source>Psychol Sci Public Interest.</source> (<year>2020</year>) <volume>21</volume>:<fpage>6</fpage>&#8211;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1177/1529100620920576</pub-id><pub-id pub-id-type="pmid">32772803</pub-id><pub-id pub-id-type="pmcid">PMC7425377</pub-id></mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ding</surname><given-names>D</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Wu</surname><given-names>W</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>Z</given-names></name><name name-style="western"><surname>Liang</surname><given-names>X</given-names></name><name name-style="western"><surname>Luo</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Prevalence and incidence of dementia in an older Chinese population over two decades: The role of education</article-title>. <source>Alzheimers Dement.</source> (<year>2020</year>) <volume>16</volume>:<fpage>1650</fpage>&#8211;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1002/alz.12159</pub-id><pub-id pub-id-type="pmid">32886438</pub-id></mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Veisani</surname><given-names>Y</given-names></name><name name-style="western"><surname>Jenabi</surname><given-names>E</given-names></name><name name-style="western"><surname>Khazaei</surname><given-names>S</given-names></name><name name-style="western"><surname>Nematollahi</surname><given-names>S</given-names></name></person-group>. <article-title>Global incidence and mortality rates in pancreatic cancer and the association with the Human Development Index: Decomposition approach</article-title>. <source>Public Health.</source> (<year>2018</year>) <volume>156</volume>:<fpage>87</fpage>&#8211;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.puhe.2017.12.015</pub-id><pub-id pub-id-type="pmid">29408193</pub-id></mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chugh</surname><given-names>SS</given-names></name><name name-style="western"><surname>Roth</surname><given-names>GA</given-names></name><name name-style="western"><surname>Gillum</surname><given-names>RF</given-names></name><name name-style="western"><surname>Mensah</surname><given-names>GA</given-names></name></person-group>. <article-title>Global burden of atrial fibrillation in developed and developing nations</article-title>. <source>Glob Heart.</source> (<year>2014</year>) <volume>9</volume>:<fpage>113</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.gheart.2014.01.004</pub-id><pub-id pub-id-type="pmid">25432121</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>S</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lin</surname><given-names>R</given-names></name><name name-style="western"><surname>Huang</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>H</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Burden of atrial fibrillation and its attributable risk factors from 1990 to 2019: An analysis of the Global Burden of Disease study 2019</article-title>. <source>Front Cardiovasc Med.</source> (<year>2022</year>) <volume>9</volume>:<fpage>997698</fpage>. <pub-id pub-id-type="doi">10.3389/fcvm.2022.997698</pub-id><pub-id pub-id-type="pmid">36386344</pub-id><pub-id pub-id-type="pmcid">PMC9643162</pub-id></mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wingerter</surname><given-names>R</given-names></name><name name-style="western"><surname>Steiger</surname><given-names>N</given-names></name><name name-style="western"><surname>Burrows</surname><given-names>A</given-names></name><name name-style="western"><surname>Estes</surname><given-names>NAM</given-names></name></person-group>. <article-title>Impact of lifestyle modification on atrial fibrillation</article-title>. <source>Am J Cardiol.</source> (<year>2020</year>) <volume>125</volume>:<fpage>289</fpage>&#8211;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1016/j.amjcard.2019.10.018</pub-id><pub-id pub-id-type="pmid">31761147</pub-id></mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morin</surname><given-names>DP</given-names></name><name name-style="western"><surname>Bernard</surname><given-names>ML</given-names></name><name name-style="western"><surname>Madias</surname><given-names>C</given-names></name><name name-style="western"><surname>Rogers</surname><given-names>PA</given-names></name><name name-style="western"><surname>Thihalolipavan</surname><given-names>S</given-names></name></person-group>. <article-title>The state of the art: Atrial fibrillation epidemiology, prevention, and treatment</article-title>. <source>Mayo Clin Proc.</source> (<year>2016</year>) <volume>91</volume>:<fpage>1778</fpage>&#8211;<lpage>810</lpage>. <pub-id pub-id-type="doi">10.1016/j.mayocp.2016.08.022</pub-id><pub-id pub-id-type="pmid">27825618</pub-id></mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Manolis</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Rosei</surname><given-names>EA</given-names></name><name name-style="western"><surname>Coca</surname><given-names>A</given-names></name><name name-style="western"><surname>Cifkova</surname><given-names>R</given-names></name><name name-style="western"><surname>Erdine</surname><given-names>SE</given-names></name><name name-style="western"><surname>Kjeldsen</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Hypertension and atrial fibrillation: Diagnostic approach, prevention and treatment. Position paper of the Working Group &#8220;Hypertension Arrhythmias and Thrombosis&#8221; of the European Society of Hypertension</article-title>. <source>J Hypertens.</source> (<year>2012</year>) <volume>30</volume>:<fpage>239</fpage>&#8211;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1097/HJH.0b013e32834f03bf</pub-id><pub-id pub-id-type="pmid">22186358</pub-id></mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cameron</surname><given-names>A</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>HK</given-names></name><name name-style="western"><surname>Lee</surname><given-names>R-P</given-names></name><name name-style="western"><surname>Doherty</surname><given-names>D</given-names></name><name name-style="western"><surname>Hall</surname><given-names>M</given-names></name><name name-style="western"><surname>Khashayar</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Biomarkers for atrial fibrillation detection after stroke: Systematic review and meta-analysis</article-title>. <source>Neurology.</source> (<year>2021</year>) <volume>97</volume>:<fpage>e1775</fpage>&#8211;<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0000000000012769</pub-id><pub-id pub-id-type="pmid">34504030</pub-id></mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nazarzadeh</surname><given-names>M</given-names></name><name name-style="western"><surname>Pinho-Gomes</surname><given-names>A-C</given-names></name><name name-style="western"><surname>Bidel</surname><given-names>Z</given-names></name><name name-style="western"><surname>Canoy</surname><given-names>D</given-names></name><name name-style="western"><surname>Dehghan</surname><given-names>A</given-names></name><name name-style="western"><surname>Byrne</surname><given-names>KS</given-names></name><etal/></person-group>. <article-title>Genetic susceptibility, elevated blood pressure, and risk of atrial fibrillation: A Mendelian randomization study</article-title>. <source>Genome Med.</source> (<year>2021</year>) <volume>13</volume>:<fpage>38</fpage>. <pub-id pub-id-type="doi">10.1186/s13073-021-00849-3</pub-id><pub-id pub-id-type="pmid">33663581</pub-id><pub-id pub-id-type="pmcid">PMC7934395</pub-id></mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rapsomaniki</surname><given-names>E</given-names></name><name name-style="western"><surname>Timmis</surname><given-names>A</given-names></name><name name-style="western"><surname>George</surname><given-names>J</given-names></name><name name-style="western"><surname>Pujades-Rodriguez</surname><given-names>M</given-names></name><name name-style="western"><surname>Shah</surname><given-names>AD</given-names></name><name name-style="western"><surname>Denaxas</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Blood pressure and incidence of twelve cardiovascular diseases: Lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people</article-title>. <source>Lancet.</source> (<year>2014</year>) <volume>383</volume>:<fpage>1899</fpage>&#8211;<lpage>911</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(14)60685-1</pub-id><pub-id pub-id-type="pmid">24881994</pub-id><pub-id pub-id-type="pmcid">PMC4042017</pub-id></mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alonso</surname><given-names>A</given-names></name><name name-style="western"><surname>Krijthe</surname><given-names>BP</given-names></name><name name-style="western"><surname>Aspelund</surname><given-names>T</given-names></name><name name-style="western"><surname>Stepas</surname><given-names>KA</given-names></name><name name-style="western"><surname>Pencina</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Moser</surname><given-names>CB</given-names></name><etal/></person-group>. <article-title>Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: The CHARGE-AF consortium</article-title>. <source>J Am Heart Assoc.</source> (<year>2013</year>) <volume>2</volume>:<fpage>e000102</fpage>. <pub-id pub-id-type="doi">10.1161/JAHA.112.000102</pub-id><pub-id pub-id-type="pmid">23537808</pub-id><pub-id pub-id-type="pmcid">PMC3647274</pub-id></mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khurshid</surname><given-names>S</given-names></name><name name-style="western"><surname>Choi</surname><given-names>SH</given-names></name><name name-style="western"><surname>Weng</surname><given-names>L-C</given-names></name><name name-style="western"><surname>Wang</surname><given-names>EY</given-names></name><name name-style="western"><surname>Trinquart</surname><given-names>L</given-names></name><name name-style="western"><surname>Benjamin</surname><given-names>EJ</given-names></name><etal/></person-group>. <article-title>Frequency of cardiac rhythm abnormalities in a half million adults</article-title>. <source>Circ Arrhythm Electrophysiol.</source> (<year>2018</year>) <volume>11</volume>:<fpage>e006273</fpage>. <pub-id pub-id-type="doi">10.1161/CIRCEP.118.006273</pub-id><pub-id pub-id-type="pmid">29954742</pub-id><pub-id pub-id-type="pmcid">PMC6051725</pub-id></mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cao</surname><given-names>X</given-names></name><name name-style="western"><surname>Broughton</surname><given-names>ST</given-names></name><name name-style="western"><surname>Waits</surname><given-names>GS</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>T</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Soliman</surname><given-names>EZ</given-names></name></person-group>. <article-title>Interrelations between hypertension and electrocardiographic left ventricular hypertrophy and their associations with cardiovascular mortality</article-title>. <source>Am J Cardiol.</source> (<year>2019</year>) <volume>123</volume>:<fpage>274</fpage>&#8211;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/j.amjcard.2018.10.006</pub-id><pub-id pub-id-type="pmid">30390988</pub-id></mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soliman</surname><given-names>EZ</given-names></name><name name-style="western"><surname>Byington</surname><given-names>RP</given-names></name><name name-style="western"><surname>Bigger</surname><given-names>JT</given-names></name><name name-style="western"><surname>Evans</surname><given-names>G</given-names></name><name name-style="western"><surname>Okin</surname><given-names>PM</given-names></name><name name-style="western"><surname>Goff</surname><given-names>DC</given-names></name><etal/></person-group>. <article-title>Effect of intensive blood pressure lowering on left ventricular hypertrophy in patients with diabetes mellitus: Action to control cardiovascular risk in diabetes blood pressure trial</article-title>. <source>Hypertension.</source> (<year>2015</year>) <volume>66</volume>:<fpage>1123</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.115.06236</pub-id><pub-id pub-id-type="pmid">26459421</pub-id><pub-id pub-id-type="pmcid">PMC4644090</pub-id></mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ogunmoroti</surname><given-names>O</given-names></name><name name-style="western"><surname>Michos</surname><given-names>ED</given-names></name><name name-style="western"><surname>Aronis</surname><given-names>KN</given-names></name><name name-style="western"><surname>Salami</surname><given-names>JA</given-names></name><name name-style="western"><surname>Blankstein</surname><given-names>R</given-names></name><name name-style="western"><surname>Virani</surname><given-names>SS</given-names></name><etal/></person-group>. <article-title>Life's Simple 7 and the risk of atrial fibrillation: The Multi-Ethnic Study of Atherosclerosis</article-title>. <source>Atherosclerosis.</source> (<year>2018</year>) <volume>275</volume>:<fpage>174</fpage>&#8211;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2018.05.050</pub-id><pub-id pub-id-type="pmid">29920438</pub-id></mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gumprecht</surname><given-names>J</given-names></name><name name-style="western"><surname>Domek</surname><given-names>M</given-names></name><name name-style="western"><surname>Lip</surname><given-names>GYH</given-names></name><name name-style="western"><surname>Shantsila</surname><given-names>A</given-names></name></person-group>. <article-title>Invited review: Hypertension and atrial fibrillation: epidemiology, pathophysiology, and implications for management</article-title>. <source>J Hum Hypertens.</source> (<year>2019</year>) <volume>33</volume>:<fpage>824</fpage>&#8211;<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1038/s41371-019-0279-7</pub-id><pub-id pub-id-type="pmid">31690818</pub-id></mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>C</given-names></name><name name-style="western"><surname>Liu</surname><given-names>L</given-names></name><name name-style="western"><surname>Yu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shen</surname><given-names>G</given-names></name><name name-style="western"><surname>Huang</surname><given-names>J</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Association of systolic blood pressure with atrial fibrillation among treated hypertensive patients</article-title>. <source>Ann Palliat Med.</source> (<year>2020</year>) <volume>9</volume>:<fpage>1752</fpage>&#8211;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.21037/apm-19-649</pub-id><pub-id pub-id-type="pmid">32527128</pub-id></mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>D</given-names></name><name name-style="western"><surname>Yang</surname><given-names>P-S</given-names></name><name name-style="western"><surname>Kim</surname><given-names>T-H</given-names></name><name name-style="western"><surname>Jang</surname><given-names>E</given-names></name><name name-style="western"><surname>Shin</surname><given-names>H</given-names></name><name name-style="western"><surname>Kim</surname><given-names>HY</given-names></name><etal/></person-group>. <article-title>Ideal blood pressure in patients with atrial fibrillation</article-title>. <source>J Am Coll Cardiol.</source> (<year>2018</year>) <volume>72</volume>:<fpage>1233</fpage>&#8211;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2018.05.076</pub-id><pub-id pub-id-type="pmid">30190001</pub-id></mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wanahita</surname><given-names>N</given-names></name><name name-style="western"><surname>Messerli</surname><given-names>FH</given-names></name><name name-style="western"><surname>Bangalore</surname><given-names>S</given-names></name><name name-style="western"><surname>Gami</surname><given-names>AS</given-names></name><name name-style="western"><surname>Somers</surname><given-names>VK</given-names></name><name name-style="western"><surname>Steinberg</surname><given-names>JS</given-names></name></person-group>. <article-title>Atrial fibrillation and obesity&#8212;Results of a meta-analysis</article-title>. <source>Am Heart J.</source> (<year>2008</year>) <volume>155</volume>:<fpage>310</fpage>&#8211;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.ahj.2007.10.004</pub-id><pub-id pub-id-type="pmid">18215602</pub-id></mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>M</given-names></name><name name-style="western"><surname>Song</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>B</given-names></name><name name-style="western"><surname>Xie</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>Elevated levels of body mass index and waist circumference, but not high variability, are associated with an increased risk of atrial fibrillation</article-title>. <source>BMC Med.</source> (<year>2022</year>) <volume>20</volume>:<fpage>215</fpage>. <pub-id pub-id-type="doi">10.1186/s12916-022-02413-1</pub-id><pub-id pub-id-type="pmid">35765047</pub-id><pub-id pub-id-type="pmcid">PMC9241273</pub-id></mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Korantzopoulos</surname><given-names>P</given-names></name><name name-style="western"><surname>Kolettis</surname><given-names>TM</given-names></name></person-group>. <article-title>Obesity and the risk of new-onset atrial fibrillation</article-title>. <source>J Am Med Assoc.</source> (<year>2004</year>) <volume>292</volume>:<fpage>2471</fpage>&#8211;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1001/jama.292.20.2471</pub-id><pub-id pub-id-type="pmid">15562125</pub-id></mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vincent</surname><given-names>HK</given-names></name><name name-style="western"><surname>Powers</surname><given-names>SK</given-names></name><name name-style="western"><surname>Stewart</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Shanely</surname><given-names>RA</given-names></name><name name-style="western"><surname>Demirel</surname><given-names>H</given-names></name><name name-style="western"><surname>Naito</surname><given-names>H</given-names></name></person-group>. <article-title>Obesity is associated with increased myocardial oxidative stress</article-title>. <source>Int J Obes Relat Metab Disord.</source> (<year>1999</year>) <volume>23</volume>:<fpage>67</fpage>&#8211;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1038/sj.ijo.0800761</pub-id><pub-id pub-id-type="pmid">10094579</pub-id></mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lavie</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Pandey</surname><given-names>A</given-names></name><name name-style="western"><surname>Lau</surname><given-names>DH</given-names></name><name name-style="western"><surname>Alpert</surname><given-names>MA</given-names></name><name name-style="western"><surname>Sanders</surname><given-names>P</given-names></name></person-group>. <article-title>Obesity and atrial fibrillation prevalence, pathogenesis, and prognosis: Effects of weight loss and exercise</article-title>. <source>J Am Coll Cardiol.</source> (<year>2017</year>) <volume>70</volume>:<fpage>2022</fpage>&#8211;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1016/j.jacc.2017.09.002</pub-id><pub-id pub-id-type="pmid">29025560</pub-id></mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Senoo</surname><given-names>K</given-names></name><name name-style="western"><surname>Nakata</surname><given-names>M</given-names></name><name name-style="western"><surname>Teramukai</surname><given-names>S</given-names></name><name name-style="western"><surname>Yamamoto</surname><given-names>T</given-names></name><name name-style="western"><surname>Nishimura</surname><given-names>H</given-names></name><name name-style="western"><surname>Matoba</surname><given-names>S</given-names></name></person-group>. <article-title>Age-specific association between body mass index and the incidence of atrial fibrillation in Japanese men</article-title>. <source>Circ Rep.</source> (<year>2020</year>) <volume>2</volume>:<fpage>466</fpage>&#8211;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1253/circrep.CR-20-0067</pub-id><pub-id pub-id-type="pmid">33693271</pub-id><pub-id pub-id-type="pmcid">PMC7819657</pub-id></mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guglin</surname><given-names>M</given-names></name><name name-style="western"><surname>Maradia</surname><given-names>K</given-names></name><name name-style="western"><surname>Chen</surname><given-names>R</given-names></name><name name-style="western"><surname>Curtis</surname><given-names>AB</given-names></name></person-group>. <article-title>Relation of obesity to recurrence rate and burden of atrial fibrillation</article-title>. <source>Am J Cardiol.</source> (<year>2011</year>) <volume>107</volume>:<fpage>579</fpage>&#8211;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/j.amjcard.2010.10.018</pub-id><pub-id pub-id-type="pmid">21195377</pub-id></mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tsang</surname><given-names>TSM</given-names></name><name name-style="western"><surname>Barnes</surname><given-names>ME</given-names></name><name name-style="western"><surname>Miyasaka</surname><given-names>Y</given-names></name><name name-style="western"><surname>Cha</surname><given-names>SS</given-names></name><name name-style="western"><surname>Bailey</surname><given-names>KR</given-names></name><name name-style="western"><surname>Verzosa</surname><given-names>GC</given-names></name><etal/></person-group>. <article-title>Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: A longitudinal cohort study of 21 years</article-title>. <source>Eur Heart J.</source> (<year>2008</year>) <volume>29</volume>:<fpage>2227</fpage>&#8211;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehn324</pub-id><pub-id pub-id-type="pmid">18611964</pub-id><pub-id pub-id-type="pmcid">PMC2733739</pub-id></mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tadic</surname><given-names>M</given-names></name><name name-style="western"><surname>Ivanovic</surname><given-names>B</given-names></name><name name-style="western"><surname>Cuspidi</surname><given-names>C</given-names></name></person-group>. <article-title>What do we currently know about metabolic syndrome and atrial fibrillation?</article-title><source>Clin Cardiol.</source> (<year>2013</year>) <volume>36</volume>:<fpage>654</fpage>&#8211;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1002/clc.22163</pub-id><pub-id pub-id-type="pmid">23788255</pub-id><pub-id pub-id-type="pmcid">PMC6649365</pub-id></mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>S</given-names></name><name name-style="western"><surname>Guo</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>G</given-names></name><name name-style="western"><surname>Yang</surname><given-names>H</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>L</given-names></name><name name-style="western"><surname>Sun</surname><given-names>Y</given-names></name></person-group>. <article-title>Gender discrepancies in predictors for newly onset cardiovascular events and metabolic syndrome in older adults patients from rural China</article-title>. <source>Front Cardiovasc Med.</source> (<year>2022</year>) <volume>9</volume>:<fpage>995128</fpage>. <pub-id pub-id-type="doi">10.3389/fcvm.2022.995128</pub-id><pub-id pub-id-type="pmid">36505366</pub-id><pub-id pub-id-type="pmcid">PMC9726899</pub-id></mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Watanabe</surname><given-names>H</given-names></name><name name-style="western"><surname>Tanabe</surname><given-names>N</given-names></name><name name-style="western"><surname>Watanabe</surname><given-names>T</given-names></name><name name-style="western"><surname>Darbar</surname><given-names>D</given-names></name><name name-style="western"><surname>Roden</surname><given-names>DM</given-names></name><name name-style="western"><surname>Sasaki</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study [published correction appears in Circulation. 2010 Aug 17;122:e433]</article-title>. <source>Circulation</source>. (<year>2008</year>) <volume>117</volume>:<fpage>1255</fpage>&#8211;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.107.744466</pub-id><pub-id pub-id-type="pmid">18285562</pub-id><pub-id pub-id-type="pmcid">PMC2637133</pub-id></mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>GBD</surname><given-names>2016 Mortality Collaborators</given-names></name></person-group>. <article-title>Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970&#8211;2016: A systematic analysis for the Global Burden of Disease Study 2016</article-title>. <source>Lancet</source>. (<year>2017</year>) <volume>390</volume>:<fpage>1084</fpage>&#8211;<lpage>150</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(17)31833-0</pub-id><pub-id pub-id-type="pmid">28919115</pub-id><pub-id pub-id-type="pmcid">PMC5605514</pub-id></mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>GBD 2016 Disease and Injury Incidence and Prevalence Collaborators</collab></person-group>. <article-title>Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990&#8211;2016: A systematic analysis for the Global Burden of Disease Study 2016</article-title>. <source>Lancet</source>. (<year>2017</year>) <volume>390</volume>:<fpage>1211</fpage>&#8211;<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(17)32154-2</pub-id><pub-id pub-id-type="pmid">28919117</pub-id><pub-id pub-id-type="pmcid">PMC5605509</pub-id></mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>GBD 2016 Causes of Death Collaborators</collab></person-group>. <article-title>Global, regional, and national age-sex specific mortality for 264 causes of death, 1980&#8211;2016: A systematic analysis for the Global Burden of Disease Study 2016</article-title>. <source>Lancet</source>. (<year>2017</year>) <volume>390</volume>:<fpage>1151</fpage>&#8211;<lpage>210</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(17)32152-9</pub-id><pub-id pub-id-type="pmid">28919116</pub-id><pub-id pub-id-type="pmcid">PMC5605883</pub-id></mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holt</surname><given-names>A</given-names></name><name name-style="western"><surname>Gislason</surname><given-names>GH</given-names></name><name name-style="western"><surname>Schou</surname><given-names>M</given-names></name><name name-style="western"><surname>Zareini</surname><given-names>B</given-names></name><name name-style="western"><surname>Biering-S&#248;rensen</surname><given-names>T</given-names></name><name name-style="western"><surname>Phelps</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>New-onset atrial fibrillation: Incidence, characteristics, and related events following a national COVID-19 lockdown of 56 million people</article-title>. <source>Eur Heart J.</source> (<year>2020</year>) <volume>41</volume>:<fpage>3072</fpage>&#8211;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehaa494</pub-id><pub-id pub-id-type="pmid">32578859</pub-id><pub-id pub-id-type="pmcid">PMC7337750</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>